data_1pc0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pc0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' HG11 ' A' ' 37' ' ' VAL . 9.3 mt . . . . . 0 C--O 1.246 0.873 0 CA-C-O 120.548 0.213 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.429 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 5.1 ttt -100.32 123.6 44.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 21' ' ' GLU . 6.7 p -136.9 153.31 29.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' N ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -107.58 122.49 46.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 174.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 17.7 t -128.93 138.24 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.428 ' N ' HG12 ' A' ' 22' ' ' VAL . 2.7 m -123.37 117.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.3 mt-10 -147.4 177.24 9.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.666 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 9.7 m . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.325 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 51' ' ' LYS . 3.3 t . . . . . 0 C--O 1.245 0.866 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.591 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.3 115.61 1.67 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.649 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.65 -179.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 121.963 0.887 . . . . 0.0 111.229 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.649 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.9 mttt -75.77 121.59 22.79 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.45 177.63 22.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.133 -175.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.95 149.48 27.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.319 -0.941 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -118.57 144.81 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 122.672 1.225 . . . . 0.0 113.424 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 C--N 1.315 -0.908 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.796 178.463 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mt -118.37 124.06 46.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 124.24 44.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -130.88 143.62 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.62 -179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.446 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 4.4 ttm -123.94 126.49 46.44 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.269 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.599 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 6.0 p -103.4 -88.75 0.4 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.181 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -141.16 -53.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.348 -0.22 . . . . 0.0 110.934 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 31' ' ' VAL . 14.4 tptm -61.55 -14.79 32.67 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 154.47 -166.85 32.36 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.762 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 2.0 pt? -124.31 134.57 53.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.29 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 147.24 49.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.153 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.8 m -119.24 125.88 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.721 -179.816 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 91.9 m -124.18 122.8 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.542 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.443 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.7 p90 -134.77 149.44 50.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.559 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 15.6 ptp180 -124.52 123.77 40.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.34 141.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' HH2' ' HB2' ' A' ' 21' ' ' GLU . 2.9 m-90 -124.64 124.78 42.94 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.225 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.441 ' CE1' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.13 175.68 5.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.995 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 5.19 7.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.609 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.84 -52.29 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.87 -178.3 7.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 pp -125.73 131.38 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.261 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.7 ttp -134.43 154.66 51.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.997 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -123.2 130.39 52.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 29.2 mm -124.01 124.64 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.1 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 179.505 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.246 0.898 0 CA-C-O 120.795 0.331 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.68 127.49 53.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.709 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.9 m -143.59 175.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 3.2 tt0 -119.6 122.83 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 47.9 t -131.01 145.29 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.66 119.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.538 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.505 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . 6.0 pt-20 -146.63 176.3 9.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.754 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.402 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 18.2 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.62 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.6 115.21 1.56 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -160.79 -178.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 O-C-N 121.78 -0.835 . . . . 0.0 111.113 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.643 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 5.1 mmtp -74.41 121.66 21.76 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.58 177.68 22.97 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.971 -1.109 . . . . 0.0 114.853 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -110.26 149.41 30.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.431 -0.885 . . . . 0.0 111.006 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 32.6 m -120.88 124.23 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.698 0.761 . . . . 0.0 112.428 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 22.0 t . . . . . 0 N--CA 1.444 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.538 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.07 124.36 51.34 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.622 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' VAL . 3.5 pttp -115.24 124.38 51.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.453 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.8 mt -127.75 136.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.424 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.31 128.18 49.58 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.665 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.582 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 4.2 p -107.09 -88.22 0.47 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.249 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 33' ' ' ILE . 1.1 mt-10 -138.63 -55.61 0.62 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 122.35 -0.219 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.66 -16.77 11.67 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.358 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 153.32 -163.14 30.54 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.304 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.23 136.59 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.388 . . . . 0.0 110.389 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -126.88 147.44 50.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.31 128.04 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.514 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG3' ' CB ' ' A' ' 24' ' ' GLU . 5.9 mmp_? . . . . . 0 C--O 1.238 0.477 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.7 m -123.65 122.76 38.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -136.6 156.1 49.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.339 0.59 . . . . 0.0 111.934 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.709 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 16.5 mtt180 -124.89 125.04 43.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 19.9 m -117.8 138.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.637 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.6 m-90 -124.27 124.78 43.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.601 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -127.26 164.0 22.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -69.44 66.42 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.69 -35.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.425 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.26 168.21 5.68 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 111.481 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.9 127.88 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.59 159.43 41.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.822 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.83 128.73 49.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 tp -124.48 124.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.432 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 pttt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 179.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' A' ' 67' ' ' TYR . 4.9 mp . . . . . 0 C--O 1.245 0.862 0 CA-C-O 120.731 0.3 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.9 mtt -103.99 123.07 46.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 64' ' ' ARG . 98.4 t -134.94 146.79 29.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' CB ' ' CH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -96.24 122.2 38.85 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 174.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.464 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 12.1 t -128.85 137.24 57.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.16 117.01 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HB3' ' CD ' ' A' ' 61' ' ' ARG . 16.1 pt-20 -148.5 177.25 9.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.257 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.876 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 2.9 t . . . . . 0 C--O 1.249 1.039 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.609 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.31 115.09 1.57 Allowed Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.637 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -159.18 -179.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.894 0.854 . . . . 0.0 110.698 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.637 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.8 mttp -76.39 121.35 22.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.84 177.61 22.45 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.416 -1.373 . . . . 0.0 115.427 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.62 148.52 29.22 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.293 -0.953 . . . . 0.0 111.094 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG11 ' CG1' ' A' ' 47' ' ' ILE . 33.9 m -122.44 124.25 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.683 0.754 . . . . 0.0 112.836 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 m . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.073 178.319 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.62 124.19 51.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.041 -0.663 . . . . 0.0 111.571 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.41 124.33 52.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG1' HG11 ' A' ' 37' ' ' VAL . 2.4 mp -128.9 140.77 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.54 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.485 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 3.9 ppp? -119.68 124.36 46.07 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.888 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.524 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 23.0 p -131.23 -92.72 0.41 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.568 0.543 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.615 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tt0 -90.39 -91.28 0.14 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -41.48 -29.68 0.17 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.46 -135.61 5.87 Favored Glycine 0 C--O 1.241 0.557 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.257 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 48' ' ' MET . 6.4 mp -100.37 124.96 46.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.192 0.52 . . . . 0.0 111.998 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -128.49 138.11 52.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.947 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.95 127.07 69.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 111.812 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.284 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.465 ' CD ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.54 0 CA-C-O 120.893 0.378 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 m -124.03 123.17 39.78 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 3.4 p90 -139.14 162.39 35.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.458 0.646 . . . . 0.0 111.965 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.559 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -124.59 123.67 40.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' HG23 ' A' ' 20' ' ' VAL . 11.8 p -108.84 139.26 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.484 ' CH2' ' CB ' ' A' ' 21' ' ' GLU . 1.9 m-90 -124.03 124.21 42.04 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.919 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 4.2 t80 -120.23 159.19 25.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.952 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.33 66.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.79 -50.39 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.699 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.32 166.97 27.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.04 137.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.4 tpp -136.76 160.1 39.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.76 128.93 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.594 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.457 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 mp -124.09 124.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.042 0.449 . . . . 0.0 111.577 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.8 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 1.5 mp . . . . . 0 C--O 1.245 0.853 0 CA-C-O 120.702 0.286 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.45 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -104.49 123.63 47.84 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 64' ' ' ARG . 8.1 p -134.32 146.8 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.635 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.6 mt-10 -100.18 121.51 41.56 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 ' CG2' HG12 ' A' ' 47' ' ' ILE . 43.9 t -133.41 146.84 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -124.55 118.59 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.197 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 4.1 mt-10 -147.1 177.06 9.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.482 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.587 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' ' 52' ' ' GLY . 13.0 p . . . . . 0 C--O 1.247 0.937 0 CA-C-O 121.307 0.575 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.627 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -133.33 115.71 1.59 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.639 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -160.3 -179.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.521 -0.988 . . . . 0.0 111.415 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -76.69 121.28 23.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.37 177.76 22.75 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.924 -1.131 . . . . 0.0 114.662 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -109.42 146.5 34.37 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.617 -0.791 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 1.6 m -124.19 125.87 71.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.379 0.609 . . . . 0.0 111.805 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.647 179.418 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.01 124.77 52.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.818 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 124.39 49.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.555 HG12 ' CG2' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -122.61 130.49 74.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.392 -178.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.425 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.22 124.74 43.69 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 50' ' ' GLU . 1.6 p -109.27 -89.22 0.48 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.909 -0.717 . . . . 0.0 111.325 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' N ' ' OG1' ' A' ' 49' ' ' THR . 37.0 tt0 -130.43 -59.86 1.01 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.172 -0.33 . . . . 0.0 111.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.492 ' N ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.27 -8.01 1.49 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' HG21 ' A' ' 31' ' ' VAL . . . 144.76 -166.4 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CB ' ' HB3' ' A' ' 48' ' ' MET . 2.2 pt? -127.89 138.13 52.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.15 149.1 52.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.377 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.21 127.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 111.139 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.56 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 5.8 mmp_? . . . . . 0 C--O 1.236 0.377 0 CA-C-O 120.457 0.17 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.4 m -124.26 122.87 38.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.119 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 1.5 p90 -135.51 151.74 50.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.554 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.2 mmt180 -124.37 123.84 41.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 20' ' ' VAL . 10.8 p -118.82 146.41 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.635 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 1.6 m-90 -124.54 124.62 42.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.454 -1.703 . . . . 0.0 110.321 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CZ ' HG13 ' A' ' 65' ' ' VAL . 3.6 m-85 -110.89 175.39 5.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.123 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -73.92 61.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.631 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.72 -67.67 0.18 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.0 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -124.05 168.73 12.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.048 0.452 . . . . 0.0 111.528 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.5 pt -128.57 139.36 52.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.325 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.03 160.76 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.51 130.2 52.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.431 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -123.95 124.76 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.599 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.525 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.838 0 CA-C-O 120.785 0.326 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.562 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 16.8 mtp -109.92 124.62 51.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.601 ' CG1' ' O ' ' A' ' 64' ' ' ARG . 81.9 t -130.12 141.3 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.907 -0.495 . . . . 0.0 111.876 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' OE2' ' CE3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -88.51 121.09 30.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 175.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 17.7 t -129.37 137.83 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -174.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.09 118.07 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.519 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 5.5 mt-10 -146.61 176.21 10.01 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.252 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.339 179.513 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG23 ' OG1' ' A' ' 49' ' ' THR . 2.7 p . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -133.33 114.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.702 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -160.43 -175.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 O-C-N 121.625 -0.927 . . . . 0.0 110.214 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 4.0 mmpt? -76.05 120.78 21.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.56 176.37 19.94 Favored Glycine 0 CA--C 1.501 -0.811 0 C-N-CA 119.579 -1.295 . . . . 0.0 115.054 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 145.3 31.6 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.502 -0.849 . . . . 0.0 111.633 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.514 HG11 ' HB ' ' A' ' 20' ' ' VAL . 19.0 m -123.22 124.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.594 178.056 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.9 124.37 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.332 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' CD ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 ttpt -116.7 124.31 49.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.48 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 2.9 mp -130.34 143.87 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.519 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.461 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -124.72 129.8 51.19 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.044 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.702 ' C ' HG12 ' A' ' 33' ' ' ILE . 4.4 p -134.77 -114.62 0.2 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 123.803 0.689 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.19 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.526 ' CB ' ' HB ' ' A' ' 31' ' ' VAL . 1.3 tttm -44.15 -57.99 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.2 -135.68 2.62 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.724 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 48' ' ' MET . 0.0 OUTLIER -103.07 127.43 50.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.046 -0.577 . . . . 0.0 112.238 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -128.33 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.763 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' CG1' ' CD ' ' A' ' 46' ' ' LYS . 27.2 m -118.23 127.26 75.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 112.115 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.659 179.149 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' N ' ' NE ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.516 0.198 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -123.96 123.06 39.56 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 1.7 p90 -133.71 147.15 51.34 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.944 0.402 . . . . 0.0 111.164 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.601 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -123.78 122.59 38.45 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 20' ' ' VAL . 12.3 p -98.01 126.38 51.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -126.17 125.17 42.03 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.077 0.941 . . . . 0.0 111.155 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -132.35 169.71 16.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.886 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -71.66 61.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.38 -44.27 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.665 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 163.41 27.64 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.439 0.638 . . . . 0.0 112.225 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.48 127.66 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.179 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.8 mmt -130.86 144.52 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.18 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -105.21 126.03 51.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.428 HG22 ' CZ ' ' A' ' 63' ' ' PHE . 25.5 mt -124.36 124.7 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.939 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.846 0 CA-C-O 120.801 0.334 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.9 ttt -103.41 124.91 49.6 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.745 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.8 m -143.77 175.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.554 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.4 mt-10 -116.81 122.07 43.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 22.5 t -127.03 131.77 70.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.22 117.17 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 122.295 1.045 . . . . 0.0 109.004 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.3 mp0 -148.35 176.16 10.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.264 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.2 m . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG13 ' N ' ' A' ' 52' ' ' GLY . 2.5 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 120.963 0.411 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' C ' HG12 ' A' ' 33' ' ' ILE . . . -132.82 114.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.75 HG13 ' N ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -162.55 -172.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 122.682 1.229 . . . . 0.0 110.415 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.75 122.4 26.54 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.99 177.46 23.43 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.443 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.02 147.89 32.69 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.003 -1.099 . . . . 0.0 110.173 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.433 ' CG1' HG23 ' A' ' 47' ' ' ILE . 33.9 m -123.53 125.31 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.877 178.35 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -112.18 123.96 51.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.344 -178.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 123.63 37.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.46 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 7.6 mt -128.83 139.69 51.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.211 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.514 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 35.2 ttm -123.5 124.41 42.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.547 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 71.3 p -97.97 -68.1 0.82 Allowed 'General case' 0 C--N 1.347 0.481 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.456 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.75 ' N ' HG13 ' A' ' 33' ' ' ILE . 8.3 tt0 -174.83 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -70.55 -9.97 58.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 155.36 -179.77 31.09 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.517 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 48' ' ' MET . 1.9 pt? -126.3 133.37 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.336 -0.432 . . . . 0.0 109.94 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 172.96 11.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 111.653 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 129.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.483 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.884 0.85 . . . . 0.0 112.396 -179.147 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.463 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.95 123.05 39.55 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.974 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.22 140.0 49.79 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.371 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.745 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.3 mtt180 -124.57 125.79 44.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 16.6 m -123.18 139.13 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.646 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.4 m-90 -124.08 124.78 43.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.855 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.409 ' CZ ' HD22 ' A' ' 18' ' ' LEU . 7.3 m-85 -112.0 175.13 5.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.454 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -81.39 59.48 4.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.882 0.372 . . . . 0.0 110.65 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.66 -50.48 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.704 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.78 163.81 31.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.46 129.86 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.37 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.67 147.58 52.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.2 129.32 49.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.12 124.48 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.883 179.645 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mp . . . . . 0 C--O 1.244 0.795 0 CA-C-O 121.041 0.448 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.412 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 30.8 mtt -107.29 123.56 48.5 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' A' ' 65' ' ' VAL . 97.5 t -132.82 145.22 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.578 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.6 tt0 -87.26 122.2 30.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.527 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 22.2 t -126.49 133.73 68.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -174.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.64 116.83 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.97 176.96 9.75 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.389 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.639 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.66 115.19 1.55 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.631 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.57 -179.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-O 121.592 0.71 . . . . 0.0 110.464 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 4.4 mtpm? -75.98 121.65 23.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.11 177.22 22.91 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 118.791 -1.671 . . . . 0.0 116.164 -174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.96 145.67 28.37 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 113.87 -1.165 . . . . 0.0 110.72 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 20' ' ' VAL . 3.1 m -123.64 127.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.312 178.323 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.518 -0.25 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.04 123.81 51.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.537 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -113.45 123.1 49.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.463 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 5.2 mt -132.05 144.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.102 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.494 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 5.7 ttp -124.02 124.21 42.06 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.1 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.592 ' HB ' ' N ' ' A' ' 33' ' ' ILE . 9.5 p -132.21 -92.94 0.37 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.617 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 3.9 tp10 -89.4 -93.89 0.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' N ' ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -38.53 -30.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 151.83 -142.73 9.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.393 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.14 128.25 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 111.008 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 148.25 52.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.631 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.57 126.12 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.347 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.578 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.1 m -124.32 123.69 40.76 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.286 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -144.02 174.22 11.05 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.516 0.674 . . . . 0.0 111.84 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -124.44 124.51 42.47 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.732 ' HA ' HG21 ' A' ' 20' ' ' VAL . 9.1 p -104.31 141.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 2.0 m-90 -124.45 124.25 41.9 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.75 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CZ ' ' CG2' ' A' ' 65' ' ' VAL . 69.5 m-85 -115.28 175.47 5.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.935 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 56.21 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.857 0.361 . . . . 0.0 110.447 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.0 -52.81 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.97 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 165.61 26.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.934 0.397 . . . . 0.0 111.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.29 134.66 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.307 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.9 mmt -140.75 168.47 19.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.995 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -101.99 130.12 48.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.46 ' CG2' ' CD2' ' A' ' 63' ' ' PHE . 1.4 tt -124.72 124.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.793 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.545 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 1.9 mp . . . . . 0 C--O 1.245 0.848 0 CA-C-O 120.807 0.336 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.39 127.07 49.56 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.673 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 12.1 m -142.88 175.15 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -121.63 121.31 37.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 47' ' ' ILE . 33.1 t -131.72 143.41 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 -175.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.72 117.98 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.29 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -148.25 174.63 11.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.992 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.434 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.322 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 51' ' ' LYS . 1.5 t . . . . . 0 C--O 1.248 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 33' ' ' ILE . . . -133.13 114.1 1.34 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.785 HG12 ' C ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -160.89 -175.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 110.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -73.87 121.06 20.32 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 175.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.85 177.57 20.77 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.601 -1.285 . . . . 0.0 115.403 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -111.4 144.39 40.69 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 113.935 -1.132 . . . . 0.0 111.016 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 27.8 m -123.99 125.89 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.505 0.669 . . . . 0.0 112.535 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.366 178.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -107.95 124.13 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.07 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -110.26 124.23 51.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.449 HG12 HG22 ' A' ' 22' ' ' VAL . 3.0 tp -127.14 135.94 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.24 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -122.35 124.32 43.43 Favored 'General case' 0 C--O 1.251 1.141 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.785 ' C ' HG12 ' A' ' 33' ' ' ILE . 81.4 p -135.18 -104.02 0.22 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.129 0.893 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' CB ' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.71 -85.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.7 tttp -43.55 -28.5 0.38 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.58 -131.68 5.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.869 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.13 125.45 44.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.124 0.487 . . . . 0.0 111.625 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 137.43 52.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.177 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.0 128.15 65.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.669 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.111 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 13.9 mmt180 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.7 m -124.26 124.15 41.79 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.298 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.77 153.7 51.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.247 0.546 . . . . 0.0 111.684 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.673 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 1.7 mtm-85 -123.96 124.91 43.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.574 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 58.0 t -115.31 138.43 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m-90 -124.11 124.6 42.87 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.858 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 83.4 m-85 -110.35 175.3 5.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.182 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 58.48 2.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.415 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.0 -56.21 0.14 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.985 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -132.75 164.58 26.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.519 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.35 129.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mtp -136.02 158.08 45.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.024 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.48 55.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.621 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.425 HG22 ' CD1' ' A' ' 63' ' ' PHE . 7.0 tp -127.0 133.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.235 0.541 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.693 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 4.4 mp . . . . . 0 C--O 1.247 0.935 0 CA-C-O 120.745 0.307 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.05 126.34 51.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 5.9 m -144.0 175.36 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.539 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.7 mm-40 -118.72 121.34 39.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 14.3 t -130.66 140.9 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m -124.5 118.32 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.864 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.7 176.3 9.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.162 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 8.7 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.638 ' O ' HG23 ' A' ' 33' ' ' ILE . . . -135.25 114.61 1.26 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.652 HG12 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -163.22 -173.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.622 -0.928 . . . . 0.0 109.841 178.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.26 122.22 21.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 176.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.04 177.35 22.78 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.277 -0.963 . . . . 0.0 114.748 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.65 148.9 31.28 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.397 -0.902 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -128.32 138.68 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.591 0.71 . . . . 0.0 112.666 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.1 179.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.96 124.13 49.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.288 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' CG ' ' CG1' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -108.87 123.65 49.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.518 HG13 ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -125.95 129.39 72.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.504 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.2 ptm -123.8 124.54 42.91 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.388 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.591 ' C ' HG12 ' A' ' 33' ' ' ILE . 3.1 p -112.25 -90.87 0.49 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.652 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -129.57 -58.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.449 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.562 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . 1.4 tptp -55.02 -16.3 2.71 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.636 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 31' ' ' VAL . . . 149.53 -162.28 29.02 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.077 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp -121.84 124.81 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.348 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 154.24 38.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' CG ' ' A' ' 46' ' ' LYS . 34.9 m -114.26 127.72 71.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.341 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.322 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.3 m -124.83 124.16 41.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.862 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -131.84 147.26 52.47 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.0 0.429 . . . . 0.0 111.296 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.699 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -124.38 124.74 43.0 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HA ' HG13 ' A' ' 20' ' ' VAL . 25.3 t -119.39 139.93 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.594 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.6 m-90 -123.54 124.79 43.61 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.748 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -123.43 175.57 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.998 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.73 7.11 9.17 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.14 -32.85 1.44 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.734 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -175.35 0.28 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.627 0.251 . . . . 0.0 110.768 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 71' ' ' ILE . 36.5 mt -124.17 135.58 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.315 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mmt -135.43 156.86 48.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -126.85 134.31 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.017 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 tp -124.01 124.66 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.986 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.912 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 ttt -104.68 127.43 52.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.782 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.3 m -143.75 175.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -120.08 122.23 40.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 39.7 t -130.4 142.15 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.55 118.84 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.873 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 6.3 pt-20 -146.22 176.0 10.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.274 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.6 p . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.659 179.548 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 52' ' ' GLY . 6.3 t . . . . . 0 C--O 1.25 1.081 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.734 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -134.26 114.94 1.38 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -161.57 -174.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-O 121.848 0.832 . . . . 0.0 109.915 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 82.3 mttt -71.36 122.01 19.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.59 177.65 22.24 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.622 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -110.01 149.52 29.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.114 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 29.8 m -122.31 124.96 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.37 0.605 . . . . 0.0 112.515 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.385 178.43 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -111.39 124.28 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.99 124.71 45.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.948 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.473 HG23 ' CG1' ' A' ' 37' ' ' VAL . 1.7 mp -127.85 137.87 56.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.102 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.416 ' HB3' ' CB ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.91 129.59 50.69 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.254 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.681 ' C ' HG12 ' A' ' 33' ' ' ILE . 20.7 p -106.05 -93.64 0.37 Allowed 'General case' 0 C--N 1.352 0.675 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.575 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.65 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 -58.35 0.91 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 122.327 -0.233 . . . . 0.0 111.591 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.28 -18.08 14.89 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.647 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 157.69 -163.53 32.68 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.517 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.416 ' CB ' ' HB3' ' A' ' 48' ' ' MET . 2.3 pt? -128.1 139.16 52.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.954 0.407 . . . . 0.0 110.771 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -124.78 145.2 49.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.694 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 m -123.04 127.61 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.179 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.216 179.774 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 6.1 mmp_? . . . . . 0 C--O 1.235 0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.3 m -124.28 123.58 40.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -135.7 154.03 51.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.557 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.782 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 mtp180 -125.4 127.52 46.69 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 16.0 m -119.0 140.13 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.671 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.7 m-90 -125.61 128.43 47.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.126 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 35.4 t80 -126.8 163.03 24.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.516 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.03 65.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.76 -43.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.613 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -160.72 170.64 20.37 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -127.62 135.7 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.276 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 mtt -136.69 160.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -123.1 134.43 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.462 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 2.1 mt -123.78 124.64 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.651 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.564 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.199 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' HG11 ' A' ' 37' ' ' VAL . 9.3 mt -71.19 75.61 0.7 Allowed 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.548 0.213 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.429 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 5.1 ttt -100.32 123.6 44.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 21' ' ' GLU . 6.7 p -136.9 153.31 29.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' N ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -107.58 122.49 46.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 174.155 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 17.7 t -128.93 138.24 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.428 ' N ' HG12 ' A' ' 22' ' ' VAL . 2.7 m -123.37 117.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.3 mt-10 -147.4 177.24 9.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.666 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.733 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 9.7 m 89.9 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.325 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.37 82.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.769 2.312 . . . . 0.0 112.812 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 25' ' ' SER . 6.7 t30 177.77 157.39 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -56.16 -23.15 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -177.43 55.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 1.0 OUTLIER -66.27 -68.73 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.461 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 51' ' ' LYS . 3.3 t -116.94 87.7 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.866 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.591 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.3 115.61 1.67 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.649 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.65 -179.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 121.963 0.887 . . . . 0.0 111.229 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.649 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 17.9 mttt -75.77 121.59 22.79 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.45 177.63 22.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.133 -175.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.95 149.48 27.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.319 -0.941 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -118.57 144.81 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 122.672 1.225 . . . . 0.0 113.424 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.0 t -130.32 138.14 54.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.796 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 71.16 73.84 0.18 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.991 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.11 -44.53 12.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 -1.38 7.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.4 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -64.61 -68.79 0.33 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.774 0.321 . . . . 0.0 110.746 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -149.6 -91.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.581 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 t -92.52 175.03 6.98 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 mt -118.37 124.06 46.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.887 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 124.24 44.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.446 HG23 HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -130.88 143.62 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.62 -179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.446 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 4.4 ttm -123.94 126.49 46.44 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.269 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.599 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 6.0 p -103.4 -88.75 0.4 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.181 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.607 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -141.16 -53.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.348 -0.22 . . . . 0.0 110.934 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 31' ' ' VAL . 14.4 tptm -61.55 -14.79 32.67 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 154.47 -166.85 32.36 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.762 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 48' ' ' MET . 2.0 pt? -124.31 134.57 53.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.29 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 147.24 49.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.153 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.8 m -119.24 125.88 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.1 175.67 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.721 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.25 175.97 5.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.976 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -36.59 -33.44 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -110.69 109.4 19.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 110.999 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.93 125.96 0.86 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.227 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 54.41 -175.16 0.04 OUTLIER 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 91.9 m -124.18 122.8 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.542 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.443 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 2.7 p90 -134.77 149.44 50.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.559 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 15.6 ptp180 -124.52 123.77 40.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.34 141.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' HH2' ' HB2' ' A' ' 21' ' ' GLU . 2.9 m-90 -124.64 124.78 42.94 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.225 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.441 ' CE1' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.13 175.68 5.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.995 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 5.19 7.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.609 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.84 -52.29 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.87 -178.3 7.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 pp -125.73 131.38 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.261 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.7 ttp -134.43 154.66 51.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.997 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -123.2 130.39 52.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 63' ' ' PHE . 29.2 mm -124.01 124.64 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -127.47 134.57 49.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.72 139.41 16.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 110.915 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.302 0 N-CA-C 112.626 -0.189 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 1.4 mp -76.82 71.07 3.35 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 120.795 0.331 . . . . 0.0 110.929 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.68 127.49 53.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.709 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.9 m -143.59 175.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 3.2 tt0 -119.6 122.83 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 47.9 t -131.01 145.29 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.66 119.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.538 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.505 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . 6.0 pt-20 -146.63 176.3 9.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.754 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 69.28 99.59 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.402 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HG3' ' NH1' ' A' ' 61' ' ' ARG . 33.8 Cg_exo -59.12 -17.5 38.9 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.333 2.022 . . . . 0.0 111.652 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -36.78 151.56 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.142 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -53.42 -53.02 57.24 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.8 p -94.6 53.45 1.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -42.73 171.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.399 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 18.2 t -110.3 99.64 9.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.526 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.62 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.6 115.21 1.56 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -160.79 -178.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 O-C-N 121.78 -0.835 . . . . 0.0 111.113 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.643 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 5.1 mmtp -74.41 121.66 21.76 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.58 177.68 22.97 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.971 -1.109 . . . . 0.0 114.853 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -110.26 149.41 30.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.431 -0.885 . . . . 0.0 111.006 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 32.6 m -120.88 124.23 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.698 0.761 . . . . 0.0 112.428 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 22.0 t -134.11 149.42 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.538 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.86 95.97 10.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.804 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -42.79 -37.25 1.72 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -149.86 40.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.545 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 46.28 56.88 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 110.95 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.56 -66.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.406 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -85.03 158.06 20.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.07 124.36 51.34 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.622 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 38' ' ' VAL . 3.5 pttp -115.24 124.38 51.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.453 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.8 mt -127.75 136.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.424 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.31 128.18 49.58 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.665 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.582 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 4.2 p -107.09 -88.22 0.47 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.249 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.626 ' HB2' HG13 ' A' ' 33' ' ' ILE . 1.1 mt-10 -138.63 -55.61 0.62 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 122.35 -0.219 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.66 -16.77 11.67 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.358 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 153.32 -163.14 30.54 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.304 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.23 136.59 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.388 . . . . 0.0 110.389 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -126.88 147.44 50.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -120.31 128.04 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.97 148.46 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.514 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.47 132.29 51.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 64.23 65.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.341 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.01 177.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.206 0.527 . . . . 0.0 111.97 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.1 -111.1 0.48 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.714 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG3' ' CB ' ' A' ' 24' ' ' GLU . 5.9 mmp_? -58.68 -163.34 0.0 OUTLIER 'General case' 0 C--O 1.238 0.477 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.7 m -123.65 122.76 38.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -136.6 156.1 49.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.339 0.59 . . . . 0.0 111.934 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.709 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 16.5 mtt180 -124.89 125.04 43.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 19.9 m -117.8 138.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.637 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.6 m-90 -124.27 124.78 43.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.601 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -127.26 164.0 22.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -69.44 66.42 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.69 -35.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.425 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.26 168.21 5.68 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 111.481 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.9 127.88 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.59 159.43 41.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.822 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.83 128.73 49.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.5 tp -124.48 124.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.432 . . . . 0.0 111.303 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 pttt -126.93 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.53 137.83 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.267 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.732 0.301 . . . . 0.0 111.073 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' A' ' 67' ' ' TYR . 4.9 mp -144.32 115.84 8.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.731 0.3 . . . . 0.0 110.797 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.9 mtt -103.99 123.07 46.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 64' ' ' ARG . 98.4 t -134.94 146.79 29.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' CB ' ' CH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -96.24 122.2 38.85 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 174.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.464 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 12.1 t -128.85 137.24 57.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.16 117.01 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HB3' ' CD ' ' A' ' 61' ' ' ARG . 16.1 pt-20 -148.5 177.25 9.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.257 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.85 103.63 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.876 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.91 -5.6 14.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.589 2.193 . . . . 0.0 111.759 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.45 156.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.007 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -52.38 -49.22 64.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.783 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -79.57 -32.08 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.505 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 62.04 150.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.023 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 2.9 t -114.7 91.38 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.609 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.31 115.09 1.57 Allowed Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.637 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -159.18 -179.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.894 0.854 . . . . 0.0 110.698 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.8 mttp -76.39 121.35 22.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.84 177.61 22.45 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.416 -1.373 . . . . 0.0 115.427 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.62 148.52 29.22 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.293 -0.953 . . . . 0.0 111.094 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG11 ' CG1' ' A' ' 47' ' ' ILE . 33.9 m -122.44 124.25 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.683 0.754 . . . . 0.0 112.836 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.71 140.3 49.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.073 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.14 115.19 23.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.243 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -43.17 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.274 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -123.2 41.82 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.448 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.43 63.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.292 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 179.46 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.14 156.87 21.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.62 124.19 51.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.041 -0.663 . . . . 0.0 111.571 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -113.41 124.33 52.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.462 ' CG1' HG11 ' A' ' 37' ' ' VAL . 2.4 mp -128.9 140.77 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.54 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.485 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 3.9 ppp? -119.68 124.36 46.07 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.888 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.524 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 23.0 p -131.23 -92.72 0.41 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.568 0.543 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.615 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tt0 -90.39 -91.28 0.14 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -41.48 -29.68 0.17 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.46 -135.61 5.87 Favored Glycine 0 C--O 1.241 0.557 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.257 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' A' ' 48' ' ' MET . 6.4 mp -100.37 124.96 46.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.192 0.52 . . . . 0.0 111.998 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -128.49 138.11 52.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.947 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.95 127.07 69.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 111.812 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.96 175.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.284 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.48 175.37 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.734 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -28.48 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -111.87 164.99 12.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.1 -84.16 0.36 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.465 ' CD ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -82.35 -177.68 6.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.893 0.378 . . . . 0.0 110.866 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.0 m -124.03 123.17 39.78 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CE1' ' HB ' ' A' ' 74' ' ' ILE . 3.4 p90 -139.14 162.39 35.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.458 0.646 . . . . 0.0 111.965 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.559 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -124.59 123.67 40.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' HG23 ' A' ' 20' ' ' VAL . 11.8 p -108.84 139.26 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.484 ' CH2' ' CB ' ' A' ' 21' ' ' GLU . 1.9 m-90 -124.03 124.21 42.04 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.919 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 4.2 t80 -120.23 159.19 25.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.952 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.33 66.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 170.79 -50.39 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.699 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.32 166.97 27.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.04 137.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.4 tpp -136.76 160.1 39.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.76 128.93 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.594 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.457 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 mp -124.09 124.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.042 0.449 . . . . 0.0 111.577 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 124.95 43.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.8 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.57 134.76 11.33 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.428 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.404 ' HA2' ' CD ' ' A' ' 68' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 1.5 mp -128.94 93.34 3.58 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.702 0.286 . . . . 0.0 110.619 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.45 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -104.49 123.63 47.84 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 64' ' ' ARG . 8.1 p -134.32 146.8 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.6 mt-10 -100.18 121.51 41.56 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 ' CG2' HG12 ' A' ' 47' ' ' ILE . 43.9 t -133.41 146.84 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -124.55 118.59 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.197 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 4.1 mt-10 -147.1 177.06 9.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.482 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 75.84 107.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.587 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.96 -12.63 35.48 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.389 2.059 . . . . 0.0 111.579 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -40.0 159.89 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.807 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -59.23 -49.47 77.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.362 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.3 t -88.99 -27.42 20.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 45.6 -171.77 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.782 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG21 ' N ' ' A' ' 52' ' ' GLY . 13.0 p -136.3 109.72 9.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-O 121.307 0.575 . . . . 0.0 110.719 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.627 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -133.33 115.71 1.59 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -160.3 -179.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.521 -0.988 . . . . 0.0 111.415 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -76.69 121.28 23.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.37 177.76 22.75 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.924 -1.131 . . . . 0.0 114.662 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -109.42 146.5 34.37 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.617 -0.791 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 1.6 m -124.19 125.87 71.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.379 0.609 . . . . 0.0 111.805 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.21 135.6 62.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.647 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.22 113.38 21.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.443 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.04 -46.14 16.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.378 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.4 m -162.16 50.03 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.12 58.36 3.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.76 -74.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.658 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 t -78.05 139.96 39.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.01 124.77 52.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.818 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 124.39 49.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.555 HG12 ' CG2' ' A' ' 22' ' ' VAL . 1.0 OUTLIER -122.61 130.49 74.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.392 -178.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.425 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.22 124.74 43.69 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 50' ' ' GLU . 1.6 p -109.27 -89.22 0.48 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.909 -0.717 . . . . 0.0 111.325 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' N ' ' OG1' ' A' ' 49' ' ' THR . 37.0 tt0 -130.43 -59.86 1.01 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.172 -0.33 . . . . 0.0 111.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.492 ' N ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.27 -8.01 1.49 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' HG21 ' A' ' 31' ' ' VAL . . . 144.76 -166.4 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CB ' ' HB3' ' A' ' 48' ' ' MET . 2.2 pt? -127.89 138.13 52.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.15 149.1 52.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.377 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.21 127.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 111.139 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -143.73 175.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.56 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.81 175.78 6.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.29 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.36 -31.45 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 111.617 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 154.34 19.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.29 129.34 4.57 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.439 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 5.8 mmp_? 56.17 -172.02 0.07 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.457 0.17 . . . . 0.0 110.637 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.4 m -124.26 122.87 38.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.119 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 1.5 p90 -135.51 151.74 50.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.554 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 1.2 mmt180 -124.37 123.84 41.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' HG22 ' A' ' 20' ' ' VAL . 10.8 p -118.82 146.41 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.635 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 1.6 m-90 -124.54 124.62 42.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.454 -1.703 . . . . 0.0 110.321 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CZ ' HG13 ' A' ' 65' ' ' VAL . 3.6 m-85 -110.89 175.39 5.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.123 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' CD ' ' HA2' ' A' ' 17' ' ' GLY . 1.9 mtmp? -73.92 61.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.631 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.72 -67.67 0.18 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.0 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -124.05 168.73 12.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.048 0.452 . . . . 0.0 111.528 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.5 pt -128.57 139.36 52.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.325 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.03 160.76 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.51 130.2 52.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.431 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -123.95 124.76 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.599 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -125.35 128.58 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.3 152.82 21.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.725 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -120.72 159.95 24.32 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.785 0.326 . . . . 0.0 110.727 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.562 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 16.8 mtp -109.92 124.62 51.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.601 ' CG1' ' O ' ' A' ' 64' ' ' ARG . 81.9 t -130.12 141.3 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.907 -0.495 . . . . 0.0 111.876 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' OE2' ' CE3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -88.51 121.09 30.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 175.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 17.7 t -129.37 137.83 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -174.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.09 118.07 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.519 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 5.5 mt-10 -146.61 176.21 10.01 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.252 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m 61.87 120.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.339 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.53 11.93 3.2 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.735 2.29 . . . . 0.0 112.418 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.28 168.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -57.28 -39.62 76.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.172 0.511 . . . . 0.0 110.263 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -103.61 -27.03 12.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 61.11 171.8 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.101 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG23 ' OG1' ' A' ' 49' ' ' THR . 2.7 p -122.35 94.97 3.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.682 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -133.33 114.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.702 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -160.43 -175.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 O-C-N 121.625 -0.927 . . . . 0.0 110.214 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 4.0 mmpt? -76.05 120.78 21.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.56 176.37 19.94 Favored Glycine 0 CA--C 1.501 -0.811 0 C-N-CA 119.579 -1.295 . . . . 0.0 115.054 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 145.3 31.6 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.502 -0.849 . . . . 0.0 111.633 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.514 HG11 ' HB ' ' A' ' 20' ' ' VAL . 19.0 m -123.22 124.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.04 142.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.594 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.92 118.37 27.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.93 -44.36 9.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.337 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -163.7 45.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 59.94 57.36 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -172.1 -65.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.931 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.8 p -84.83 158.04 20.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.9 124.37 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.332 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' CD ' ' CD2' ' A' ' 53' ' ' LEU . 6.9 ttpt -116.7 124.31 49.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.48 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 2.9 mp -130.34 143.87 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.519 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.461 ' HB2' ' HG ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -124.72 129.8 51.19 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.044 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.702 ' C ' HG12 ' A' ' 33' ' ' ILE . 4.4 p -134.77 -114.62 0.2 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 123.803 0.689 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HB2' HG21 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -64.19 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.526 ' CB ' ' HB ' ' A' ' 31' ' ' VAL . 1.3 tttm -44.15 -57.99 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.2 -135.68 2.62 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.724 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 48' ' ' MET . 0.0 OUTLIER -103.07 127.43 50.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.046 -0.577 . . . . 0.0 112.238 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -128.33 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.763 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' CG1' ' CD ' ' A' ' 46' ' ' LYS . 27.2 m -118.23 127.26 75.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 112.115 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.96 166.3 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.659 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' ARG . . . -123.51 123.75 41.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.448 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER 25.24 39.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 178.46 -168.26 0.08 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.059 0.457 . . . . 0.0 111.399 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.37 129.09 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.986 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' N ' ' NE ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 58.99 -175.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.931 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -123.96 123.06 39.56 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 1.7 p90 -133.71 147.15 51.34 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.944 0.402 . . . . 0.0 111.164 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.601 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -123.78 122.59 38.45 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 20' ' ' VAL . 12.3 p -98.01 126.38 51.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -126.17 125.17 42.03 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.077 0.941 . . . . 0.0 111.155 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -132.35 169.71 16.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.886 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -71.66 61.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.38 -44.27 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.665 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 163.41 27.64 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.439 0.638 . . . . 0.0 112.225 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.48 127.66 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.179 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.8 mmt -130.86 144.52 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.18 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -105.21 126.03 51.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.428 HG22 ' CZ ' ' A' ' 63' ' ' PHE . 25.5 mt -124.36 124.7 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.939 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -131.6 147.05 52.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.04 170.98 35.11 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.29 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.386 . . . . 0.0 111.071 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.245 0 N-CA-C 112.881 -0.087 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -94.84 90.97 6.22 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.801 0.334 . . . . 0.0 110.593 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.9 ttt -103.41 124.91 49.6 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.745 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.8 m -143.77 175.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.554 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.4 mt-10 -116.81 122.07 43.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 22.5 t -127.03 131.77 70.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.22 117.17 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 122.295 1.045 . . . . 0.0 109.004 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.599 ' C ' ' CD ' ' A' ' 26' ' ' PRO . 1.3 mp0 -148.35 176.16 10.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.264 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.594 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 1.2 m 88.55 -16.78 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' CD ' ' C ' ' A' ' 24' ' ' GLU . 20.0 Cg_endo -61.27 -19.51 64.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 121.778 1.671 . . . . 0.0 109.722 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -16.34 61.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.385 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.7 -67.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.432 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -96.63 -136.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.447 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -162.58 104.33 1.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG13 ' N ' ' A' ' 52' ' ' GLY . 2.5 t -151.45 94.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.093 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' C ' HG12 ' A' ' 33' ' ' ILE . . . -132.82 114.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.75 HG13 ' N ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -162.55 -172.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 122.682 1.229 . . . . 0.0 110.415 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.75 122.4 26.54 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.99 177.46 23.43 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.443 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.02 147.89 32.69 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.003 -1.099 . . . . 0.0 110.173 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 ' CG1' HG23 ' A' ' 47' ' ' ILE . 33.9 m -123.53 125.31 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.44 130.09 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.877 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -83.78 112.32 19.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.518 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -47.1 -54.18 11.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.2 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 m -150.07 44.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.735 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.35 64.05 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.624 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -179.05 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -77.08 138.16 39.38 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 37' ' ' VAL . 0.1 OUTLIER -112.18 123.96 51.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.344 -178.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 123.63 37.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.46 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 7.6 mt -128.83 139.69 51.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.211 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.514 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 35.2 ttm -123.5 124.41 42.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.547 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 71.3 p -97.97 -68.1 0.82 Allowed 'General case' 0 C--N 1.347 0.481 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.456 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.75 ' N ' HG13 ' A' ' 33' ' ' ILE . 8.3 tt0 -174.83 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -70.55 -9.97 58.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 155.36 -179.77 31.09 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.517 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 48' ' ' MET . 1.9 pt? -126.3 133.37 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.336 -0.432 . . . . 0.0 109.94 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 172.96 11.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 111.653 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.1 m -103.78 129.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.483 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.93 158.51 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.884 0.85 . . . . 0.0 112.396 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 59' ' ' ARG . . . -143.84 176.15 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.348 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -59.12 68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.262 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 57' ' ' ALA . 3.4 mtm180 -143.68 -162.99 1.56 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.822 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 61' ' ' ARG . . . -54.7 113.58 3.64 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.888 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 150.86 163.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.567 0.747 . . . . 0.0 109.081 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.95 123.05 39.55 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.974 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.22 140.0 49.79 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.371 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.745 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.3 mtt180 -124.57 125.79 44.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 16.6 m -123.18 139.13 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.646 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.4 m-90 -124.08 124.78 43.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.855 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.409 ' CZ ' HD22 ' A' ' 18' ' ' LEU . 7.3 m-85 -112.0 175.13 5.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.454 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -81.39 59.48 4.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.882 0.372 . . . . 0.0 110.65 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.66 -50.48 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.704 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.78 163.81 31.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.46 129.86 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.37 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.67 147.58 52.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.2 129.32 49.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.12 124.48 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -125.81 129.45 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.883 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.68 124.59 6.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.32 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.802 0.334 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.638 -0.185 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 5.0 mp -113.99 102.75 10.48 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.041 0.448 . . . . 0.0 110.637 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.412 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 30.8 mtt -107.29 123.56 48.5 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' A' ' 65' ' ' VAL . 97.5 t -132.82 145.22 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.578 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.6 tt0 -87.26 122.2 30.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.527 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 22.2 t -126.49 133.73 68.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -174.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.64 116.83 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.97 176.96 9.75 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.389 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 61.7 114.48 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.639 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.15 10.55 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.541 2.161 . . . . 0.0 111.992 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -43.23 161.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.544 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -30.68 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.673 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.1 t -103.31 -28.54 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 62.0 152.38 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.773 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -115.79 95.69 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.66 115.19 1.55 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.631 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.57 -179.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-O 121.592 0.71 . . . . 0.0 110.464 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 4.4 mtpm? -75.98 121.65 23.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.11 177.22 22.91 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 118.791 -1.671 . . . . 0.0 116.164 -174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.96 145.67 28.37 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 113.87 -1.165 . . . . 0.0 110.72 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.488 HG13 HG22 ' A' ' 20' ' ' VAL . 3.1 m -123.64 127.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.0 t -127.48 132.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.312 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.93 107.87 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.7 91.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m 58.6 31.83 21.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 57.95 65.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.783 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.5 -76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 m -81.87 150.27 27.87 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.04 123.81 51.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.537 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -113.45 123.1 49.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.463 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 5.2 mt -132.05 144.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.102 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.494 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 5.7 ttp -124.02 124.21 42.06 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.1 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.592 ' HB ' ' N ' ' A' ' 33' ' ' ILE . 9.5 p -132.21 -92.94 0.37 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.617 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 3.9 tp10 -89.4 -93.89 0.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' N ' ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -38.53 -30.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 151.83 -142.73 9.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.393 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.14 128.25 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 111.008 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 148.25 52.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.631 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.57 126.12 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.347 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.39 140.05 50.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.578 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.75 124.91 43.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 58.46 111.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.48 174.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.14 0.495 . . . . 0.0 111.706 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.22 11.81 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.012 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.12 126.27 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.1 m -124.32 123.69 40.76 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.286 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -144.02 174.22 11.05 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.516 0.674 . . . . 0.0 111.84 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 0.8 OUTLIER -124.44 124.51 42.47 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.732 ' HA ' HG21 ' A' ' 20' ' ' VAL . 9.1 p -104.31 141.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 2.0 m-90 -124.45 124.25 41.9 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.75 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CZ ' ' CG2' ' A' ' 65' ' ' VAL . 69.5 m-85 -115.28 175.47 5.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.935 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 56.21 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.857 0.361 . . . . 0.0 110.447 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.0 -52.81 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.97 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 165.61 26.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.934 0.397 . . . . 0.0 111.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.29 134.66 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.307 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.9 mmt -140.75 168.47 19.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.995 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -101.99 130.12 48.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.46 ' CG2' ' CD2' ' A' ' 63' ' ' PHE . 1.4 tt -124.72 124.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.793 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 140.12 51.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.545 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.31 124.89 9.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 111.173 -179.783 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.379 -0.288 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 1.9 mp -95.12 78.24 3.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.807 0.336 . . . . 0.0 110.866 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.39 127.07 49.56 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.673 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 12.1 m -142.88 175.15 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -121.63 121.31 37.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 47' ' ' ILE . 33.1 t -131.72 143.41 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 -175.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.72 117.98 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.29 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.709 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -148.25 174.63 11.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.992 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.654 ' N ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER 34.5 41.13 0.17 Allowed Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.322 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.709 ' HD3' ' C ' ' A' ' 24' ' ' GLU . 75.8 Cg_endo -99.81 6.33 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.797 2.331 . . . . 0.0 109.519 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.44 -28.31 9.44 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.438 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -44.07 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.17 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' GLU . 1.7 p -125.18 -102.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.226 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 25' ' ' SER . 0.9 OUTLIER 166.86 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 O-C-N 122.401 -0.187 . . . . 0.0 111.444 179.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 51' ' ' LYS . 1.5 t -130.74 82.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 33' ' ' ILE . . . -133.13 114.1 1.34 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.785 HG12 ' C ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -160.89 -175.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 110.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -73.87 121.06 20.32 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 175.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.85 177.57 20.77 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.601 -1.285 . . . . 0.0 115.403 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -111.4 144.39 40.69 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 113.935 -1.132 . . . . 0.0 111.016 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 27.8 m -123.99 125.89 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.505 0.669 . . . . 0.0 112.535 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 m -128.28 136.7 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.366 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.04 107.4 17.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.15 95.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m 54.47 32.77 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.05 69.97 0.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.29 -80.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m -85.97 160.18 19.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -107.95 124.13 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.07 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -110.26 124.23 51.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.449 HG12 HG22 ' A' ' 22' ' ' VAL . 3.0 tp -127.14 135.94 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.24 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -122.35 124.32 43.43 Favored 'General case' 0 C--O 1.251 1.141 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.885 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.785 ' C ' HG12 ' A' ' 33' ' ' ILE . 81.4 p -135.18 -104.02 0.22 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.129 0.893 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' CB ' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.71 -85.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HB3' HG21 ' A' ' 31' ' ' VAL . 1.7 tttp -43.55 -28.5 0.38 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.58 -131.68 5.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.869 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.13 125.45 44.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.124 0.487 . . . . 0.0 111.625 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 137.43 52.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.177 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -109.0 128.15 65.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.669 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.9 t -128.37 137.97 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.111 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.25 131.92 51.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.676 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 62.2 75.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.42 -179.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.318 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' CZ ' ' A' ' 63' ' ' PHE . . . 126.64 122.58 2.57 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.138 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 13.9 mmt180 68.33 -172.98 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.708 0.254 . . . . 0.0 110.456 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.7 m -124.26 124.15 41.79 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.298 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.77 153.7 51.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.247 0.546 . . . . 0.0 111.684 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.673 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 1.7 mtm-85 -123.96 124.91 43.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.574 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 58.0 t -115.31 138.43 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m-90 -124.11 124.6 42.87 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.858 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CE1' ' CG1' ' A' ' 65' ' ' VAL . 83.4 m-85 -110.35 175.3 5.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.182 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 58.48 2.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.415 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.0 -56.21 0.14 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.985 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -132.75 164.58 26.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.519 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.35 129.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mtp -136.02 158.08 45.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.024 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.48 55.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.621 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.425 HG22 ' CD1' ' A' ' 63' ' ' PHE . 7.0 tp -127.0 133.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.235 0.541 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 145.93 52.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.36 145.96 27.12 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.603 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.979 -0.048 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' VAL . 4.4 mp -92.88 101.64 14.0 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.745 0.307 . . . . 0.0 110.341 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.05 126.34 51.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 5.9 m -144.0 175.36 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.539 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.7 mm-40 -118.72 121.34 39.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 14.3 t -130.66 140.9 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' N ' HG13 ' A' ' 22' ' ' VAL . 5.9 m -124.5 118.32 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.864 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.7 176.3 9.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.162 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.36 104.53 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.26 -5.19 13.21 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.554 2.169 . . . . 0.0 112.106 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -38.76 157.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.907 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -50.89 -51.84 47.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -79.53 -34.33 41.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.726 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 31' ' ' VAL . 3.2 tt0 62.58 149.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 51' ' ' LYS . 8.7 p -111.05 93.26 2.4 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.186 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.638 ' O ' HG23 ' A' ' 33' ' ' ILE . . . -135.25 114.61 1.26 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.652 HG12 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -163.22 -173.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.622 -0.928 . . . . 0.0 109.841 178.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.26 122.22 21.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 176.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.04 177.35 22.78 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.277 -0.963 . . . . 0.0 114.748 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.65 148.9 31.28 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.397 -0.902 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -128.32 138.68 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.591 0.71 . . . . 0.0 112.666 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 9.6 p -126.53 131.48 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.1 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 24.4 m-20 72.16 74.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.815 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -88.53 -64.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.5 p -103.21 24.75 10.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -99.8 -78.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.637 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -137.08 -106.03 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.253 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 p -82.64 151.8 26.15 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.96 124.13 49.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.288 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' CG ' ' CG1' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -108.87 123.65 49.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.518 HG13 ' CG1' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -125.95 129.39 72.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.504 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.2 ptm -123.8 124.54 42.91 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.388 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.591 ' C ' HG12 ' A' ' 33' ' ' ILE . 3.1 p -112.25 -90.87 0.49 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.652 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -129.57 -58.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.449 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.562 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . 1.4 tptp -55.02 -16.3 2.71 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.636 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' N ' HG22 ' A' ' 31' ' ' VAL . . . 149.53 -162.28 29.02 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.077 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp -121.84 124.81 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.348 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 154.24 38.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' CG ' ' A' ' 46' ' ' LYS . 34.9 m -114.26 127.72 71.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.341 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.71 175.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.322 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.83 175.23 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.206 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -68.79 67.7 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.124 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.5 72.68 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' CZ ' ' A' ' 63' ' ' PHE . . . 160.24 144.92 4.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.329 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER 58.37 -177.39 0.08 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.3 m -124.83 124.16 41.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.862 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -131.84 147.26 52.47 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.0 0.429 . . . . 0.0 111.296 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.699 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -124.38 124.74 43.0 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HA ' HG13 ' A' ' 20' ' ' VAL . 25.3 t -119.39 139.93 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.594 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.6 m-90 -123.54 124.79 43.61 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.748 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -123.43 175.57 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.998 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.73 7.11 9.17 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.14 -32.85 1.44 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.734 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -175.35 0.28 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.627 0.251 . . . . 0.0 110.768 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.439 HG23 HD13 ' A' ' 71' ' ' ILE . 36.5 mt -124.17 135.58 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.315 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mmt -135.43 156.86 48.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -126.85 134.31 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.017 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 tp -124.01 124.66 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 129.72 49.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -119.36 160.25 14.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.341 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -97.15 113.09 24.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 ttt -104.68 127.43 52.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.782 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.3 m -143.75 175.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -120.08 122.23 40.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.52 ' O ' ' HA2' ' A' ' 32' ' ' GLY . 39.7 t -130.4 142.15 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.55 118.84 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.873 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 6.3 pt-20 -146.22 176.0 10.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.274 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.6 p 54.57 102.58 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.659 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.22 -2.9 11.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.39 2.06 . . . . 0.0 111.72 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -35.16 155.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.386 0.674 . . . . 0.0 112.113 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -47.58 -35.18 8.76 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.173 0.511 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 1.8 p -113.43 66.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.458 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -37.56 147.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 52' ' ' GLY . 6.3 t -105.96 85.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.734 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -134.26 114.94 1.38 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -161.57 -174.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-O 121.848 0.832 . . . . 0.0 109.915 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 82.3 mttt -71.36 122.01 19.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.59 177.65 22.24 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.622 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -110.01 149.52 29.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.114 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 18' ' ' LEU . 29.8 m -122.31 124.96 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.37 0.605 . . . . 0.0 112.515 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.19 137.93 55.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.385 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 118.18 26.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.671 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.77 99.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.997 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.0 t 44.63 38.34 2.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.383 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 59.02 68.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -166.64 -79.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.59 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.23 163.3 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.929 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -111.39 124.28 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.99 124.71 45.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.948 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.473 HG23 ' CG1' ' A' ' 37' ' ' VAL . 1.7 mp -127.85 137.87 56.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.102 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.416 ' HB3' ' CB ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.91 129.59 50.69 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.254 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.681 ' C ' HG12 ' A' ' 33' ' ' ILE . 20.7 p -106.05 -93.64 0.37 Allowed 'General case' 0 C--N 1.352 0.675 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.575 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.65 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 -58.35 0.91 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 122.327 -0.233 . . . . 0.0 111.591 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -57.28 -18.08 14.89 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.647 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 31' ' ' VAL . . . 157.69 -163.53 32.68 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.517 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.416 ' CB ' ' HB3' ' A' ' 48' ' ' MET . 2.3 pt? -128.1 139.16 52.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.954 0.407 . . . . 0.0 110.771 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -124.78 145.2 49.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.694 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 m -123.04 127.61 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.179 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.55 163.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.216 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.07 141.62 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.767 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.57 -68.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.234 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.1 156.66 41.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 0.0 111.405 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.71 124.48 0.92 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.533 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.475 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 6.1 mmp_? 63.89 -175.8 0.16 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.3 m -124.28 123.58 40.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -135.7 154.03 51.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.557 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.782 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 mtp180 -125.4 127.52 46.69 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.466 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 16.0 m -119.0 140.13 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.671 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.7 m-90 -125.61 128.43 47.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.126 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CD1' ' CD1' ' A' ' 18' ' ' LEU . 35.4 t80 -126.8 163.03 24.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.516 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.03 65.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.76 -43.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.613 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -160.72 170.64 20.37 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -127.62 135.7 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.276 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 mtt -136.69 160.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -123.1 134.43 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.462 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 2.1 mt -123.78 124.64 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.651 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.95 126.81 46.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 125.34 6.9 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.615 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.645 ' HB3' HG13 ' A' ' 37' ' ' VAL . 9.3 mt . . . . . 0 C--O 1.246 0.873 0 CA-C-O 120.548 0.213 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.435 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 5.1 ttt -100.32 123.6 44.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 64' ' ' ARG . 6.7 p -136.9 153.31 29.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HB2' ' HH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -107.58 122.49 46.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 174.155 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 47' ' ' ILE . 17.7 t -128.93 138.24 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 62' ' ' THR . 2.7 m -123.37 117.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.3 mt-10 -147.4 177.24 9.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.666 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 31' ' ' VAL . 9.7 m . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.325 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 51' ' ' LYS . 3.3 t . . . . . 0 C--O 1.245 0.866 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.3 115.61 1.67 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.65 -179.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 121.963 0.887 . . . . 0.0 111.229 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.664 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.9 mttt -75.77 121.59 22.79 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.45 177.63 22.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.133 -175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.95 149.48 27.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.319 -0.941 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.731 HG12 HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -118.57 144.81 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 122.672 1.225 . . . . 0.0 113.424 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 C--N 1.315 -0.908 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.796 178.463 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.468 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mt -118.37 124.06 46.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -121.22 124.24 44.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -130.88 143.62 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.62 -179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.463 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 4.4 ttm -123.94 126.49 46.44 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.269 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 6.0 p -103.4 -88.75 0.4 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.181 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -141.16 -53.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.348 -0.22 . . . . 0.0 110.934 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.673 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.4 tptm -61.55 -14.79 32.67 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 154.47 -166.85 32.36 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.762 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.0 pt? -124.31 134.57 53.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.29 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 147.24 49.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.153 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 46' ' ' LYS . 22.8 m -119.24 125.88 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.721 -179.816 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 23' ' ' VAL . 91.9 m -124.18 122.8 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.542 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.7 p90 -134.77 149.44 50.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 1.024 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 ptp180 -124.52 123.77 40.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.34 141.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.56 ' HH2' ' HB2' ' A' ' 21' ' ' GLU . 2.9 m-90 -124.64 124.78 42.94 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.225 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' CE1' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.13 175.68 5.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.995 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 5.19 7.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.609 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.84 -52.29 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.87 -178.3 7.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.5 pp -125.73 131.38 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.261 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 74' ' ' ILE . 7.7 ttp -134.43 154.66 51.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.997 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 74' ' ' ILE . 44.4 mtt85 -123.2 130.39 52.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.704 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.435 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 29.2 mm -124.01 124.64 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.1 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 179.505 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.246 0.898 0 CA-C-O 120.795 0.331 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.68 127.49 53.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.827 HG23 HG23 ' A' ' 22' ' ' VAL . 2.9 m -143.59 175.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 3.2 tt0 -119.6 122.83 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.916 HG21 ' CG2' ' A' ' 47' ' ' ILE . 47.9 t -131.01 145.29 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.66 119.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.538 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.503 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . 6.0 pt-20 -146.63 176.3 9.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.754 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.402 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.729 HG12 ' OG1' ' A' ' 49' ' ' THR . 18.2 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.6 115.21 1.56 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.669 HG13 ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -160.79 -178.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 O-C-N 121.78 -0.835 . . . . 0.0 111.113 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' N ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmtp -74.41 121.66 21.76 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.58 177.68 22.97 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.971 -1.109 . . . . 0.0 114.853 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -110.26 149.41 30.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.431 -0.885 . . . . 0.0 111.006 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.927 HG12 HG23 ' A' ' 47' ' ' ILE . 32.6 m -120.88 124.23 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.698 0.761 . . . . 0.0 112.428 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 22.0 t . . . . . 0 N--CA 1.444 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.538 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.07 124.36 51.34 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.622 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB3' HG12 ' A' ' 55' ' ' VAL . 3.5 pttp -115.24 124.38 51.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 37' ' ' VAL . 2.8 mt -127.75 136.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.443 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.31 128.18 49.58 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.665 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.729 ' OG1' HG12 ' A' ' 31' ' ' VAL . 4.2 p -107.09 -88.22 0.47 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.249 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HB2' HG13 ' A' ' 33' ' ' ILE . 1.1 mt-10 -138.63 -55.61 0.62 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 122.35 -0.219 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.711 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.66 -16.77 11.67 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.358 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 153.32 -163.14 30.54 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.304 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.1 pt? -127.23 136.59 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.388 . . . . 0.0 110.389 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -126.88 147.44 50.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.797 HG12 ' HB3' ' A' ' 46' ' ' LYS . 28.1 m -120.31 128.04 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.514 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CB ' ' A' ' 24' ' ' GLU . 5.9 mmp_? . . . . . 0 C--O 1.238 0.477 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.493 HG23 ' CB ' ' A' ' 75' ' ' LYS . 4.7 m -123.65 122.76 38.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.617 ' HD1' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -136.6 156.1 49.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.339 0.59 . . . . 0.0 111.934 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.734 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 16.5 mtt180 -124.89 125.04 43.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 20' ' ' VAL . 19.9 m -117.8 138.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.6 m-90 -124.27 124.78 43.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.601 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -127.26 164.0 22.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -69.44 66.42 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.69 -35.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.425 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.26 168.21 5.68 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 111.481 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.9 127.88 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.59 159.43 41.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.822 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.83 128.73 49.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 63' ' ' PHE . 1.5 tp -124.48 124.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.432 . . . . 0.0 111.303 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' CB ' HG23 ' A' ' 62' ' ' THR . 11.0 pttt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.483 ' HB2' HG23 ' A' ' 37' ' ' VAL . 4.9 mp . . . . . 0 C--O 1.245 0.862 0 CA-C-O 120.731 0.3 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.9 mtt -103.99 123.07 46.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 64' ' ' ARG . 98.4 t -134.94 146.79 29.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' CB ' ' CH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -96.24 122.2 38.85 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 174.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.97 ' CG2' HG21 ' A' ' 47' ' ' ILE . 12.1 t -128.85 137.24 57.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' THR . 3.6 m -123.16 117.01 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB3' ' CD ' ' A' ' 61' ' ' ARG . 16.1 pt-20 -148.5 177.25 9.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.257 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.876 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 51' ' ' LYS . 2.9 t . . . . . 0 C--O 1.249 1.039 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.31 115.09 1.57 Allowed Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.637 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -159.18 -179.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.894 0.854 . . . . 0.0 110.698 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.637 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.8 mttp -76.39 121.35 22.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.84 177.61 22.45 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.416 -1.373 . . . . 0.0 115.427 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.62 148.52 29.22 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.293 -0.953 . . . . 0.0 111.094 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 20' ' ' VAL . 33.9 m -122.44 124.25 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.683 0.754 . . . . 0.0 112.836 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 m . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.073 178.319 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.62 124.19 51.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.041 -0.663 . . . . 0.0 111.571 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.772 ' HE2' HD23 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -113.41 124.33 52.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.97 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.4 mp -128.9 140.77 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.54 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.505 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 3.9 ppp? -119.68 124.36 46.07 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.888 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.584 HG21 ' HB ' ' A' ' 22' ' ' VAL . 23.0 p -131.23 -92.72 0.41 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.568 0.543 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.635 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tt0 -90.39 -91.28 0.14 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.902 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -41.48 -29.68 0.17 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.46 -135.61 5.87 Favored Glycine 0 C--O 1.241 0.557 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.257 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.772 HD23 ' HE2' ' A' ' 46' ' ' LYS . 6.4 mp -100.37 124.96 46.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.192 0.52 . . . . 0.0 111.998 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -128.49 138.11 52.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.947 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' CG ' ' A' ' 46' ' ' LYS . 29.8 m -111.95 127.07 69.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.284 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.54 0 CA-C-O 120.893 0.378 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 23' ' ' VAL . 40.0 m -124.03 123.17 39.78 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 22' ' ' VAL . 3.4 p90 -139.14 162.39 35.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.458 0.646 . . . . 0.0 111.965 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 1.035 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -124.59 123.67 40.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 20' ' ' VAL . 11.8 p -108.84 139.26 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.484 ' CH2' ' CB ' ' A' ' 21' ' ' GLU . 1.9 m-90 -124.03 124.21 42.04 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.919 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 4.2 t80 -120.23 159.19 25.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.952 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.33 66.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 67' ' ' TYR . . . 170.79 -50.39 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.699 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.32 166.97 27.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.04 137.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.4 tpp -136.76 160.1 39.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.76 128.93 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.594 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.498 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.5 mp -124.09 124.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.042 0.449 . . . . 0.0 111.577 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.8 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.939 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.5 mp . . . . . 0 C--O 1.245 0.853 0 CA-C-O 120.702 0.286 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.453 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -104.49 123.63 47.84 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.99 HG11 HG13 ' A' ' 37' ' ' VAL . 8.1 p -134.32 146.8 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.6 mt-10 -100.18 121.51 41.56 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.774 HG21 HG12 ' A' ' 47' ' ' ILE . 43.9 t -133.41 146.84 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -124.55 118.59 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.197 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 4.1 mt-10 -147.1 177.06 9.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.482 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.709 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.587 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.897 HG22 ' OG1' ' A' ' 49' ' ' THR . 13.0 p . . . . . 0 C--O 1.247 0.937 0 CA-C-O 121.307 0.575 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.634 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -133.33 115.71 1.59 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -160.3 -179.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.521 -0.988 . . . . 0.0 111.415 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.651 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -76.69 121.28 23.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.37 177.76 22.75 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.924 -1.131 . . . . 0.0 114.662 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -109.42 146.5 34.37 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.617 -0.791 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.99 HG13 HG11 ' A' ' 20' ' ' VAL . 1.6 m -124.19 125.87 71.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.379 0.609 . . . . 0.0 111.805 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.647 179.418 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.01 124.77 52.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.818 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.37 124.39 49.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.774 HG12 HG21 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -122.61 130.49 74.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.392 -178.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.648 ' N ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -123.22 124.74 43.69 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.897 ' OG1' HG22 ' A' ' 31' ' ' VAL . 1.6 p -109.27 -89.22 0.48 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.909 -0.717 . . . . 0.0 111.325 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' ILE . 37.0 tt0 -130.43 -59.86 1.01 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.172 -0.33 . . . . 0.0 111.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.807 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.27 -8.01 1.49 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.76 -166.4 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.2 pt? -127.89 138.13 52.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.15 149.1 52.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.377 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' A' ' 46' ' ' LYS . 30.3 m -112.21 127.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 111.139 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG21 ' OE2' ' A' ' 24' ' ' GLU . 2.9 m . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.56 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 5.8 mmp_? . . . . . 0 C--O 1.236 0.377 0 CA-C-O 120.457 0.17 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.4 m -124.26 122.87 38.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.119 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 p90 -135.51 151.74 50.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.9 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 mmt180 -124.37 123.84 41.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG11 ' OH ' ' A' ' 67' ' ' TYR . 10.8 p -118.82 146.41 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 1.6 m-90 -124.54 124.62 42.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.454 -1.703 . . . . 0.0 110.321 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' OH ' HG11 ' A' ' 65' ' ' VAL . 3.6 m-85 -110.89 175.39 5.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.123 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -73.92 61.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.631 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.72 -67.67 0.18 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.0 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -124.05 168.73 12.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.048 0.452 . . . . 0.0 111.528 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.5 pt -128.57 139.36 52.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.325 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.03 160.76 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.51 130.2 52.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -123.95 124.76 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.599 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.525 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.838 0 CA-C-O 120.785 0.326 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.562 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 16.8 mtp -109.92 124.62 51.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 64' ' ' ARG . 81.9 t -130.12 141.3 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.907 -0.495 . . . . 0.0 111.876 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' OE2' ' CE3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -88.51 121.09 30.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 175.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.995 ' CG2' HG21 ' A' ' 47' ' ' ILE . 17.7 t -129.37 137.83 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -174.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.09 118.07 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.519 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 5.5 mt-10 -146.61 176.21 10.01 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.252 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 31' ' ' VAL . 1.4 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.339 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.875 HG22 ' OG1' ' A' ' 49' ' ' THR . 2.7 p . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -133.33 114.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.733 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -160.43 -175.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 O-C-N 121.625 -0.927 . . . . 0.0 110.214 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 4.0 mmpt? -76.05 120.78 21.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.56 176.37 19.94 Favored Glycine 0 CA--C 1.501 -0.811 0 C-N-CA 119.579 -1.295 . . . . 0.0 115.054 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 145.3 31.6 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.502 -0.849 . . . . 0.0 111.633 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.77 HG11 HG21 ' A' ' 20' ' ' VAL . 19.0 m -123.22 124.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.594 178.056 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.9 124.37 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.332 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.634 ' CG ' HG12 ' A' ' 55' ' ' VAL . 6.9 ttpt -116.7 124.31 49.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.995 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.9 mp -130.34 143.87 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.519 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.473 ' HG3' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -124.72 129.8 51.19 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.044 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.875 ' OG1' HG22 ' A' ' 31' ' ' VAL . 4.4 p -134.77 -114.62 0.2 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 123.803 0.689 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.788 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.19 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' CB ' ' HB ' ' A' ' 31' ' ' VAL . 1.3 tttm -44.15 -57.99 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.2 -135.68 2.62 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.724 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD23 ' CG ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -103.07 127.43 50.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.046 -0.577 . . . . 0.0 112.238 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -128.33 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.763 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.634 HG12 ' CG ' ' A' ' 46' ' ' LYS . 27.2 m -118.23 127.26 75.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 112.115 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.659 179.149 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' N ' ' NE ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.516 0.198 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -123.96 123.06 39.56 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.612 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 p90 -133.71 147.15 51.34 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.944 0.402 . . . . 0.0 111.164 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 1.064 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -123.78 122.59 38.45 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 20' ' ' VAL . 12.3 p -98.01 126.38 51.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.618 ' HB2' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -126.17 125.17 42.03 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.077 0.941 . . . . 0.0 111.155 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB3' HD22 ' A' ' 18' ' ' LEU . 2.1 p90 -132.35 169.71 16.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.886 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -71.66 61.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.38 -44.27 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.665 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 163.41 27.64 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.439 0.638 . . . . 0.0 112.225 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.618 HG22 ' HB2' ' A' ' 66' ' ' TRP . 9.2 pt -126.48 127.66 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.179 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.8 mmt -130.86 144.52 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.18 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -105.21 126.03 51.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.429 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 25.5 mt -124.36 124.7 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.939 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.847 HD23 ' CE2' ' A' ' 67' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.846 0 CA-C-O 120.801 0.334 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.9 ttt -103.41 124.91 49.6 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.772 HG23 HG23 ' A' ' 22' ' ' VAL . 2.8 m -143.77 175.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.4 mt-10 -116.81 122.07 43.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.994 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.5 t -127.03 131.77 70.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.22 117.17 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 122.295 1.045 . . . . 0.0 109.004 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.744 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.3 mp0 -148.35 176.16 10.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.264 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.2 m . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.888 HG12 ' OG1' ' A' ' 49' ' ' THR . 2.5 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 120.963 0.411 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.869 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -132.82 114.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -162.55 -172.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 122.682 1.229 . . . . 0.0 110.415 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -79.75 122.4 26.54 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.99 177.46 23.43 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.443 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.02 147.89 32.69 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.003 -1.099 . . . . 0.0 110.173 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.66 ' O ' HD13 ' A' ' 18' ' ' LEU . 33.9 m -123.53 125.31 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' O ' HD13 ' A' ' 45' ' ' LEU . 21.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.877 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -112.18 123.96 51.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.344 -178.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -93.9 123.63 37.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.994 ' CG2' HG21 ' A' ' 22' ' ' VAL . 7.6 mt -128.83 139.69 51.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.211 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 35.2 ttm -123.5 124.41 42.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.888 ' OG1' HG12 ' A' ' 31' ' ' VAL . 71.3 p -97.97 -68.1 0.82 Allowed 'General case' 0 C--N 1.347 0.481 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.456 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.769 ' N ' HG13 ' A' ' 33' ' ' ILE . 8.3 tt0 -174.83 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -70.55 -9.97 58.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 155.36 -179.77 31.09 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.517 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 53' ' ' LEU . 1.9 pt? -126.3 133.37 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.336 -0.432 . . . . 0.0 109.94 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 172.96 11.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 111.653 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 46' ' ' LYS . 31.1 m -103.78 129.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.483 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.744 HG11 ' HG2' ' A' ' 24' ' ' GLU . 16.6 m . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.884 0.85 . . . . 0.0 112.396 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -123.95 123.05 39.55 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.974 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.22 140.0 49.79 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.371 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.3 mtt180 -124.57 125.79 44.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 20' ' ' VAL . 16.6 m -123.18 139.13 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.709 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.4 m-90 -124.08 124.78 43.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.855 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.847 ' CE2' HD23 ' A' ' 18' ' ' LEU . 7.3 m-85 -112.0 175.13 5.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.454 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -81.39 59.48 4.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.882 0.372 . . . . 0.0 110.65 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.66 -50.48 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.704 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.78 163.81 31.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.46 129.86 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.37 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.67 147.58 52.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.2 129.32 49.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.12 124.48 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.802 ' HG3' HG23 ' A' ' 62' ' ' THR . 56.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.883 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.713 ' HB3' HG23 ' A' ' 37' ' ' VAL . 5.0 mp . . . . . 0 C--O 1.244 0.795 0 CA-C-O 121.041 0.448 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.412 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 30.8 mtt -107.29 123.56 48.5 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.022 HG13 ' O ' ' A' ' 64' ' ' ARG . 97.5 t -132.82 145.22 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.6 tt0 -87.26 122.2 30.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.957 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.2 t -126.49 133.73 68.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -174.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.64 116.83 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.97 176.96 9.75 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.389 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.639 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 ' N ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.66 115.19 1.55 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.641 ' HB ' ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -159.57 -179.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-O 121.592 0.71 . . . . 0.0 110.464 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 4.4 mtpm? -75.98 121.65 23.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.11 177.22 22.91 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 118.791 -1.671 . . . . 0.0 116.164 -174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.96 145.67 28.37 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 113.87 -1.165 . . . . 0.0 110.72 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' HB3' ' A' ' 18' ' ' LEU . 3.1 m -123.64 127.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.312 178.323 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.518 -0.25 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.04 123.81 51.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.537 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HG2' HG12 ' A' ' 55' ' ' VAL . 7.2 mtpp -113.45 123.1 49.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.957 ' CG2' HG21 ' A' ' 22' ' ' VAL . 5.2 mt -132.05 144.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.102 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.511 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 5.7 ttp -124.02 124.21 42.06 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.1 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.562 ' HB ' ' N ' ' A' ' 33' ' ' ILE . 9.5 p -132.21 -92.94 0.37 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.641 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 3.9 tp10 -89.4 -93.89 0.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.864 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -38.53 -30.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 151.83 -142.73 9.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.393 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.14 128.25 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 111.008 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 148.25 52.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.631 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 46' ' ' LYS . 35.9 m -115.57 126.12 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.347 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' HD3' ' A' ' 61' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.578 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.1 m -124.32 123.69 40.76 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.286 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -144.02 174.22 11.05 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.516 0.674 . . . . 0.0 111.84 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 1.022 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -124.44 124.51 42.47 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 67' ' ' TYR . 9.1 p -104.31 141.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 2.0 m-90 -124.45 124.25 41.9 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.75 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 69.5 m-85 -115.28 175.47 5.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.935 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 56.21 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.857 0.361 . . . . 0.0 110.447 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.0 -52.81 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.97 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 165.61 26.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.934 0.397 . . . . 0.0 111.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.29 134.66 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.307 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.9 mmt -140.75 168.47 19.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.995 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -101.99 130.12 48.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 HG21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 tt -124.72 124.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.793 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.545 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.668 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.9 mp . . . . . 0 C--O 1.245 0.848 0 CA-C-O 120.807 0.336 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.39 127.07 49.56 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 37' ' ' VAL . 12.1 m -142.88 175.15 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -121.63 121.31 37.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 63' ' ' PHE . 33.1 t -131.72 143.41 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 -175.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.72 117.98 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.29 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -148.25 174.63 11.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.992 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.611 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.322 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.977 HG22 ' HB2' ' A' ' 51' ' ' LYS . 1.5 t . . . . . 0 C--O 1.248 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -133.13 114.1 1.34 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.82 HG12 ' C ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -160.89 -175.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 110.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -73.87 121.06 20.32 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 175.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.85 177.57 20.77 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.601 -1.285 . . . . 0.0 115.403 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' HD12 ' A' ' 47' ' ' ILE . 9.6 tt0 -111.4 144.39 40.69 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 113.935 -1.132 . . . . 0.0 111.016 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.834 ' CG1' HD13 ' A' ' 47' ' ' ILE . 27.8 m -123.99 125.89 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.505 0.669 . . . . 0.0 112.535 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.366 178.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -107.95 124.13 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.07 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.709 ' HE2' HD23 ' A' ' 53' ' ' LEU . 6.8 tttt -110.26 124.23 51.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.834 HD13 ' CG1' ' A' ' 37' ' ' VAL . 3.0 tp -127.14 135.94 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.24 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.609 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -122.35 124.32 43.43 Favored 'General case' 0 C--O 1.251 1.141 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.885 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.82 ' C ' HG12 ' A' ' 33' ' ' ILE . 81.4 p -135.18 -104.02 0.22 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.129 0.893 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.71 -85.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.977 ' HB2' HG22 ' A' ' 31' ' ' VAL . 1.7 tttp -43.55 -28.5 0.38 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.58 -131.68 5.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.869 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD23 ' HE2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -99.13 125.45 44.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.124 0.487 . . . . 0.0 111.625 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 137.43 52.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.177 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 46' ' ' LYS . 15.4 m -109.0 128.15 65.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.669 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.111 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 13.9 mmt180 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.7 m -124.26 124.15 41.79 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.298 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.77 153.7 51.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.247 0.546 . . . . 0.0 111.684 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.691 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 1.7 mtm-85 -123.96 124.91 43.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 20' ' ' VAL . 58.0 t -115.31 138.43 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.65 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m-90 -124.11 124.6 42.87 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.858 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE1' HG11 ' A' ' 65' ' ' VAL . 83.4 m-85 -110.35 175.3 5.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.182 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 58.48 2.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.415 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.0 -56.21 0.14 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.985 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -132.75 164.58 26.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.519 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.35 129.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mtp -136.02 158.08 45.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.024 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.48 55.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.621 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' A' ' 63' ' ' PHE . 7.0 tp -127.0 133.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.235 0.541 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.693 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG23 ' A' ' 37' ' ' VAL . 4.4 mp . . . . . 0 C--O 1.247 0.935 0 CA-C-O 120.745 0.307 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.05 126.34 51.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.868 ' CG1' HG13 ' A' ' 65' ' ' VAL . 5.9 m -144.0 175.36 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.7 mm-40 -118.72 121.34 39.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 47' ' ' ILE . 14.3 t -130.66 140.9 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.5 118.32 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.864 174.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -146.7 176.3 9.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.162 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.645 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 49' ' ' THR . 8.7 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' CG2' ' A' ' 33' ' ' ILE . . . -135.25 114.61 1.26 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.681 HG12 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -163.22 -173.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.622 -0.928 . . . . 0.0 109.841 178.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.26 122.22 21.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 176.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.04 177.35 22.78 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.277 -0.963 . . . . 0.0 114.748 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.65 148.9 31.28 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.397 -0.902 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.676 HG21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -128.32 138.68 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.591 0.71 . . . . 0.0 112.666 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.1 179.11 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.96 124.13 49.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.288 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.888 ' CG ' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -108.87 123.65 49.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.922 HD11 HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.95 129.39 72.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.504 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.79 ' HB3' HD13 ' A' ' 53' ' ' LEU . 28.2 ptm -123.8 124.54 42.91 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.388 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 1.011 ' OG1' HG22 ' A' ' 31' ' ' VAL . 3.1 p -112.25 -90.87 0.49 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.681 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -129.57 -58.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.449 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.796 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.4 tptp -55.02 -16.3 2.71 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.636 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.53 -162.28 29.02 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.077 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 48' ' ' MET . 14.2 tp -121.84 124.81 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.348 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 154.24 38.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.888 HG12 ' CG ' ' A' ' 46' ' ' LYS . 34.9 m -114.26 127.72 71.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.341 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG11 HH11 ' A' ' 61' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.322 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.3 m -124.83 124.16 41.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.862 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -131.84 147.26 52.47 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.0 0.429 . . . . 0.0 111.296 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -124.38 124.74 43.0 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG13 ' CG1' ' A' ' 20' ' ' VAL . 25.3 t -119.39 139.93 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.663 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.6 m-90 -123.54 124.79 43.61 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.748 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -123.43 175.57 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.998 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.73 7.11 9.17 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.14 -32.85 1.44 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.734 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -175.35 0.28 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.627 0.251 . . . . 0.0 110.768 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -124.17 135.58 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.315 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mmt -135.43 156.86 48.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -126.85 134.31 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.017 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 74' ' ' ILE . 5.9 tp -124.01 124.66 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.986 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.912 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 ttt -104.68 127.43 52.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.854 HG23 HG23 ' A' ' 22' ' ' VAL . 2.3 m -143.75 175.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 4.3 tt0 -120.08 122.23 40.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.997 HG21 ' CG2' ' A' ' 47' ' ' ILE . 39.7 t -130.4 142.15 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.55 118.84 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.873 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 6.3 pt-20 -146.22 176.0 10.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.274 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.76 ' OG ' HG23 ' A' ' 31' ' ' VAL . 99.6 p . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.659 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.84 HG12 ' OG1' ' A' ' 49' ' ' THR . 6.3 t . . . . . 0 C--O 1.25 1.081 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -134.26 114.94 1.38 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.72 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -161.57 -174.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-O 121.848 0.832 . . . . 0.0 109.915 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 82.3 mttt -71.36 122.01 19.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.59 177.65 22.24 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.622 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -110.01 149.52 29.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.114 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.849 HG12 HG23 ' A' ' 47' ' ' ILE . 29.8 m -122.31 124.96 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.37 0.605 . . . . 0.0 112.515 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.75 HG23 ' HG3' ' A' ' 46' ' ' LYS . 13.7 m . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.385 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -111.39 124.28 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.811 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -120.99 124.71 45.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.948 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.997 ' CG2' HG21 ' A' ' 22' ' ' VAL . 1.7 mp -127.85 137.87 56.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.102 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.436 ' HB3' ' CB ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.91 129.59 50.69 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.254 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.84 ' OG1' HG12 ' A' ' 31' ' ' VAL . 20.7 p -106.05 -93.64 0.37 Allowed 'General case' 0 C--N 1.352 0.675 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.575 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.712 ' CB ' HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 -58.35 0.91 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 122.327 -0.233 . . . . 0.0 111.591 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.838 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.28 -18.08 14.89 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.647 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.535 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 157.69 -163.53 32.68 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.517 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.3 pt? -128.1 139.16 52.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.954 0.407 . . . . 0.0 110.771 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -124.78 145.2 49.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.694 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' ' 46' ' ' LYS . 33.9 m -123.04 127.61 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.179 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 44' ' ' THR . 10.6 p . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.216 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.476 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 6.1 mmp_? . . . . . 0 C--O 1.235 0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.3 m -124.28 123.58 40.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.796 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -135.7 154.03 51.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.557 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.811 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 mtp180 -125.4 127.52 46.69 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG12 HG11 ' A' ' 20' ' ' VAL . 16.0 m -119.0 140.13 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.7 m-90 -125.61 128.43 47.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.126 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.737 ' CD1' HD13 ' A' ' 18' ' ' LEU . 35.4 t80 -126.8 163.03 24.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.516 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.03 65.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.76 -43.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.613 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -160.72 170.64 20.37 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -127.62 135.7 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.276 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 mtt -136.69 160.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -123.1 134.43 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.71 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.1 mt -123.78 124.64 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.651 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.564 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.199 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.645 ' HB3' HG13 ' A' ' 37' ' ' VAL . 9.3 mt -71.19 75.61 0.7 Allowed 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.548 0.213 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.435 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 5.1 ttt -100.32 123.6 44.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 64' ' ' ARG . 6.7 p -136.9 153.31 29.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HB2' ' HH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -107.58 122.49 46.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 174.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 47' ' ' ILE . 17.7 t -128.93 138.24 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 62' ' ' THR . 2.7 m -123.37 117.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.3 mt-10 -147.4 177.24 9.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.666 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 9.7 m 89.9 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.325 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 51.2 Cg_exo -54.37 82.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.769 2.312 . . . . 0.0 112.812 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' CB ' ' HB2' ' A' ' 30' ' ' GLU . 6.7 t30 177.77 157.39 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -56.16 -23.15 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -177.43 55.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 1.0 OUTLIER -66.27 -68.73 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.461 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 51' ' ' LYS . 3.3 t -116.94 87.7 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.866 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.3 115.61 1.67 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.65 -179.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 121.963 0.887 . . . . 0.0 111.229 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.664 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.9 mttt -75.77 121.59 22.79 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.45 177.63 22.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.133 -175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.95 149.48 27.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.319 -0.941 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.731 HG12 HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -118.57 144.81 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 122.672 1.225 . . . . 0.0 113.424 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.0 t -130.32 138.14 54.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.796 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 71.16 73.84 0.18 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.991 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.457 ' HG3' HD21 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -86.11 -44.53 12.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 -1.38 7.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.4 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -64.61 -68.79 0.33 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.774 0.321 . . . . 0.0 110.746 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -149.6 -91.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.581 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 t -92.52 175.03 6.98 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.468 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mt -118.37 124.06 46.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -121.22 124.24 44.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -130.88 143.62 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.62 -179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.463 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 4.4 ttm -123.94 126.49 46.44 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.269 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 6.0 p -103.4 -88.75 0.4 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.181 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -141.16 -53.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.348 -0.22 . . . . 0.0 110.934 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.673 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.4 tptm -61.55 -14.79 32.67 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 154.47 -166.85 32.36 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.762 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.0 pt? -124.31 134.57 53.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.29 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 147.24 49.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.153 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 46' ' ' LYS . 22.8 m -119.24 125.88 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.1 175.67 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.721 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.25 175.97 5.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.976 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -36.59 -33.44 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -110.69 109.4 19.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 110.999 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.93 125.96 0.86 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.227 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 54.41 -175.16 0.04 OUTLIER 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 23' ' ' VAL . 91.9 m -124.18 122.8 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.542 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.7 p90 -134.77 149.44 50.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 1.024 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 ptp180 -124.52 123.77 40.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.34 141.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.56 ' HH2' ' HB2' ' A' ' 21' ' ' GLU . 2.9 m-90 -124.64 124.78 42.94 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.225 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' CE1' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.13 175.68 5.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.995 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 5.19 7.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.609 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.84 -52.29 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.87 -178.3 7.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.5 pp -125.73 131.38 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.261 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 74' ' ' ILE . 7.7 ttp -134.43 154.66 51.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.997 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 74' ' ' ILE . 44.4 mtt85 -123.2 130.39 52.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.704 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.435 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 29.2 mm -124.01 124.64 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -127.47 134.57 49.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.72 139.41 16.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 110.915 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.302 0 N-CA-C 112.626 -0.189 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.4 mp -76.82 71.07 3.35 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 120.795 0.331 . . . . 0.0 110.929 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.68 127.49 53.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.827 HG23 HG23 ' A' ' 22' ' ' VAL . 2.9 m -143.59 175.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 3.2 tt0 -119.6 122.83 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.916 HG21 ' CG2' ' A' ' 47' ' ' ILE . 47.9 t -131.01 145.29 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.496 HG13 ' OE1' ' A' ' 30' ' ' GLU . 41.7 t -124.66 119.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.538 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.503 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . 6.0 pt-20 -146.63 176.3 9.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.754 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 69.28 99.59 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.402 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.12 -17.5 38.9 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.333 2.022 . . . . 0.0 111.652 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -36.78 151.56 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.142 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -53.42 -53.02 57.24 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.8 p -94.6 53.45 1.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE1' HG13 ' A' ' 23' ' ' VAL . 1.5 pp20? -42.73 171.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.399 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.729 HG12 ' OG1' ' A' ' 49' ' ' THR . 18.2 t -110.3 99.64 9.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.526 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.6 115.21 1.56 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.669 HG13 ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -160.79 -178.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 O-C-N 121.78 -0.835 . . . . 0.0 111.113 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' N ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmtp -74.41 121.66 21.76 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.58 177.68 22.97 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.971 -1.109 . . . . 0.0 114.853 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -110.26 149.41 30.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.431 -0.885 . . . . 0.0 111.006 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.927 HG12 HG23 ' A' ' 47' ' ' ILE . 32.6 m -120.88 124.23 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.698 0.761 . . . . 0.0 112.428 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 22.0 t -134.11 149.42 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.538 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.86 95.97 10.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.804 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HG3' HG22 ' A' ' 41' ' ' THR . 15.1 pt-20 -42.79 -37.25 1.72 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.639 HG22 ' HG3' ' A' ' 40' ' ' GLU . 6.2 t -149.86 40.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.545 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 46.28 56.88 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 110.95 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.56 -66.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.406 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -85.03 158.06 20.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.07 124.36 51.34 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.622 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB3' HG12 ' A' ' 55' ' ' VAL . 3.5 pttp -115.24 124.38 51.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 37' ' ' VAL . 2.8 mt -127.75 136.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.443 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.31 128.18 49.58 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.665 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.729 ' OG1' HG12 ' A' ' 31' ' ' VAL . 4.2 p -107.09 -88.22 0.47 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.249 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HB2' HG13 ' A' ' 33' ' ' ILE . 1.1 mt-10 -138.63 -55.61 0.62 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 122.35 -0.219 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.711 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.66 -16.77 11.67 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.358 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 153.32 -163.14 30.54 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.304 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.1 pt? -127.23 136.59 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.388 . . . . 0.0 110.389 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -126.88 147.44 50.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.797 HG12 ' HB3' ' A' ' 46' ' ' LYS . 28.1 m -120.31 128.04 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.97 148.46 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.514 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.47 132.29 51.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 64.23 65.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.341 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.01 177.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.206 0.527 . . . . 0.0 111.97 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.1 -111.1 0.48 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.714 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CB ' ' A' ' 24' ' ' GLU . 5.9 mmp_? -58.68 -163.34 0.0 OUTLIER 'General case' 0 C--O 1.238 0.477 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.493 HG23 ' CB ' ' A' ' 75' ' ' LYS . 4.7 m -123.65 122.76 38.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.617 ' HD1' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -136.6 156.1 49.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.339 0.59 . . . . 0.0 111.934 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.734 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 16.5 mtt180 -124.89 125.04 43.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 20' ' ' VAL . 19.9 m -117.8 138.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.6 m-90 -124.27 124.78 43.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.601 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -127.26 164.0 22.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -69.44 66.42 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.69 -35.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.425 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.26 168.21 5.68 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 111.481 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.9 127.88 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.59 159.43 41.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.822 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.83 128.73 49.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 63' ' ' PHE . 1.5 tp -124.48 124.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.432 . . . . 0.0 111.303 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' CB ' HG23 ' A' ' 62' ' ' THR . 11.0 pttt -126.93 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.53 137.83 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.267 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.732 0.301 . . . . 0.0 111.073 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' HB2' HG23 ' A' ' 37' ' ' VAL . 4.9 mp -144.32 115.84 8.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.731 0.3 . . . . 0.0 110.797 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.9 mtt -103.99 123.07 46.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 64' ' ' ARG . 98.4 t -134.94 146.79 29.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' CB ' ' CH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -96.24 122.2 38.85 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 174.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.97 ' CG2' HG21 ' A' ' 47' ' ' ILE . 12.1 t -128.85 137.24 57.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' THR . 3.6 m -123.16 117.01 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB3' ' CD ' ' A' ' 61' ' ' ARG . 16.1 pt-20 -148.5 177.25 9.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.257 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.85 103.63 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.876 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.91 -5.6 14.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.589 2.193 . . . . 0.0 111.759 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.45 156.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.007 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -52.38 -49.22 64.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.783 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -79.57 -32.08 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.505 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 62.04 150.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.023 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 51' ' ' LYS . 2.9 t -114.7 91.38 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.31 115.09 1.57 Allowed Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.637 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -159.18 -179.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.894 0.854 . . . . 0.0 110.698 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.8 mttp -76.39 121.35 22.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.84 177.61 22.45 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.416 -1.373 . . . . 0.0 115.427 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.62 148.52 29.22 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.293 -0.953 . . . . 0.0 111.094 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 20' ' ' VAL . 33.9 m -122.44 124.25 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.683 0.754 . . . . 0.0 112.836 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.71 140.3 49.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.073 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.14 115.19 23.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.243 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -43.17 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.274 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -123.2 41.82 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.448 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.43 63.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.292 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 179.46 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.14 156.87 21.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.62 124.19 51.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.041 -0.663 . . . . 0.0 111.571 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.772 ' HE2' HD23 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -113.41 124.33 52.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.97 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.4 mp -128.9 140.77 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.54 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.505 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 3.9 ppp? -119.68 124.36 46.07 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.888 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.584 HG21 ' HB ' ' A' ' 22' ' ' VAL . 23.0 p -131.23 -92.72 0.41 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.568 0.543 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.635 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tt0 -90.39 -91.28 0.14 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.902 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -41.48 -29.68 0.17 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.46 -135.61 5.87 Favored Glycine 0 C--O 1.241 0.557 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.257 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.772 HD23 ' HE2' ' A' ' 46' ' ' LYS . 6.4 mp -100.37 124.96 46.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.192 0.52 . . . . 0.0 111.998 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -128.49 138.11 52.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.947 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' CG ' ' A' ' 46' ' ' LYS . 29.8 m -111.95 127.07 69.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -143.96 175.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.284 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -98.48 175.37 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.734 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -28.48 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -111.87 164.99 12.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.1 -84.16 0.36 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -82.35 -177.68 6.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.893 0.378 . . . . 0.0 110.866 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 23' ' ' VAL . 40.0 m -124.03 123.17 39.78 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 22' ' ' VAL . 3.4 p90 -139.14 162.39 35.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.458 0.646 . . . . 0.0 111.965 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 1.035 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -124.59 123.67 40.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 20' ' ' VAL . 11.8 p -108.84 139.26 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.484 ' CH2' ' CB ' ' A' ' 21' ' ' GLU . 1.9 m-90 -124.03 124.21 42.04 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.919 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 4.2 t80 -120.23 159.19 25.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.952 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.33 66.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 67' ' ' TYR . . . 170.79 -50.39 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.699 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.32 166.97 27.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.04 137.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.4 tpp -136.76 160.1 39.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.76 128.93 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.594 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.498 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.5 mp -124.09 124.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.042 0.449 . . . . 0.0 111.577 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 124.95 43.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.8 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.57 134.76 11.33 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.428 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' CD ' ' A' ' 68' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.939 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.5 mp -128.94 93.34 3.58 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.702 0.286 . . . . 0.0 110.619 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.453 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -104.49 123.63 47.84 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.99 HG11 HG13 ' A' ' 37' ' ' VAL . 8.1 p -134.32 146.8 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.6 mt-10 -100.18 121.51 41.56 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.774 HG21 HG12 ' A' ' 47' ' ' ILE . 43.9 t -133.41 146.84 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -124.55 118.59 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.197 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 4.1 mt-10 -147.1 177.06 9.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.482 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.709 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 75.84 107.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.587 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.96 -12.63 35.48 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.389 2.059 . . . . 0.0 111.579 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -40.0 159.89 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.807 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -59.23 -49.47 77.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.362 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.3 t -88.99 -27.42 20.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 45.6 -171.77 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.782 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.897 HG22 ' OG1' ' A' ' 49' ' ' THR . 13.0 p -136.3 109.72 9.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-O 121.307 0.575 . . . . 0.0 110.719 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.634 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -133.33 115.71 1.59 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -160.3 -179.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.521 -0.988 . . . . 0.0 111.415 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.651 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -76.69 121.28 23.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.37 177.76 22.75 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.924 -1.131 . . . . 0.0 114.662 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -109.42 146.5 34.37 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.617 -0.791 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.99 HG13 HG11 ' A' ' 20' ' ' VAL . 1.6 m -124.19 125.87 71.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.379 0.609 . . . . 0.0 111.805 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.21 135.6 62.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.647 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.432 ' OD1' ' HG ' ' A' ' 45' ' ' LEU . 5.9 m-20 -85.22 113.38 21.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.443 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 44' ' ' THR . 0.6 OUTLIER -46.04 -46.14 16.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.378 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.4 m -162.16 50.03 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.12 58.36 3.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.76 -74.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.658 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 40' ' ' GLU . 2.1 t -78.05 139.96 39.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -115.01 124.77 52.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.818 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.37 124.39 49.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.774 HG12 HG21 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -122.61 130.49 74.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.392 -178.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.648 ' N ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -123.22 124.74 43.69 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.897 ' OG1' HG22 ' A' ' 31' ' ' VAL . 1.6 p -109.27 -89.22 0.48 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.909 -0.717 . . . . 0.0 111.325 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' ILE . 37.0 tt0 -130.43 -59.86 1.01 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.172 -0.33 . . . . 0.0 111.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.807 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.27 -8.01 1.49 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.76 -166.4 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.2 pt? -127.89 138.13 52.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.15 149.1 52.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.377 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' A' ' 46' ' ' LYS . 30.3 m -112.21 127.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 111.139 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.425 HG21 ' OE2' ' A' ' 24' ' ' GLU . 2.9 m -143.73 175.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.56 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.81 175.78 6.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.29 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.36 -31.45 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 111.617 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 154.34 19.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.29 129.34 4.57 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.439 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 5.8 mmp_? 56.17 -172.02 0.07 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.457 0.17 . . . . 0.0 110.637 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.4 m -124.26 122.87 38.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.119 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 p90 -135.51 151.74 50.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.9 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 mmt180 -124.37 123.84 41.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG11 ' OH ' ' A' ' 67' ' ' TYR . 10.8 p -118.82 146.41 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 1.6 m-90 -124.54 124.62 42.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.454 -1.703 . . . . 0.0 110.321 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' OH ' HG11 ' A' ' 65' ' ' VAL . 3.6 m-85 -110.89 175.39 5.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.123 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' CD ' ' HA2' ' A' ' 17' ' ' GLY . 1.9 mtmp? -73.92 61.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.631 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.72 -67.67 0.18 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.0 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -124.05 168.73 12.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.048 0.452 . . . . 0.0 111.528 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.5 pt -128.57 139.36 52.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.325 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.03 160.76 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.51 130.2 52.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -123.95 124.76 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.599 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -125.35 128.58 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.3 152.82 21.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.725 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -120.72 159.95 24.32 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.785 0.326 . . . . 0.0 110.727 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.562 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 16.8 mtp -109.92 124.62 51.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 64' ' ' ARG . 81.9 t -130.12 141.3 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.907 -0.495 . . . . 0.0 111.876 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' OE2' ' CE3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -88.51 121.09 30.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 175.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.995 ' CG2' HG21 ' A' ' 47' ' ' ILE . 17.7 t -129.37 137.83 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -174.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.09 118.07 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.519 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 5.5 mt-10 -146.61 176.21 10.01 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.252 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 31' ' ' VAL . 1.4 m 61.87 120.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.339 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.53 11.93 3.2 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.735 2.29 . . . . 0.0 112.418 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.28 168.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -57.28 -39.62 76.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.172 0.511 . . . . 0.0 110.263 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -103.61 -27.03 12.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 61.11 171.8 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.101 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.875 HG22 ' OG1' ' A' ' 49' ' ' THR . 2.7 p -122.35 94.97 3.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.682 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -133.33 114.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.733 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -160.43 -175.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 O-C-N 121.625 -0.927 . . . . 0.0 110.214 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 4.0 mmpt? -76.05 120.78 21.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.56 176.37 19.94 Favored Glycine 0 CA--C 1.501 -0.811 0 C-N-CA 119.579 -1.295 . . . . 0.0 115.054 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 145.3 31.6 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.502 -0.849 . . . . 0.0 111.633 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.77 HG11 HG21 ' A' ' 20' ' ' VAL . 19.0 m -123.22 124.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.04 142.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.594 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.92 118.37 27.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.93 -44.36 9.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.337 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -163.7 45.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 59.94 57.36 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -172.1 -65.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.931 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.8 p -84.83 158.04 20.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.9 124.37 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.332 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.634 ' CG ' HG12 ' A' ' 55' ' ' VAL . 6.9 ttpt -116.7 124.31 49.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.995 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.9 mp -130.34 143.87 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.519 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.473 ' HG3' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -124.72 129.8 51.19 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.044 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.875 ' OG1' HG22 ' A' ' 31' ' ' VAL . 4.4 p -134.77 -114.62 0.2 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 123.803 0.689 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.788 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.19 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' CB ' ' HB ' ' A' ' 31' ' ' VAL . 1.3 tttm -44.15 -57.99 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.2 -135.68 2.62 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.724 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD23 ' CG ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -103.07 127.43 50.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.046 -0.577 . . . . 0.0 112.238 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -128.33 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.763 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.634 HG12 ' CG ' ' A' ' 46' ' ' LYS . 27.2 m -118.23 127.26 75.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 112.115 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 57' ' ' ALA . 2.5 t -139.96 166.3 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.659 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' ARG . . . -123.51 123.75 41.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER 25.24 39.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 178.46 -168.26 0.08 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.059 0.457 . . . . 0.0 111.399 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.37 129.09 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.986 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' N ' ' NE ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 58.99 -175.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.931 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -123.96 123.06 39.56 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.612 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 p90 -133.71 147.15 51.34 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.944 0.402 . . . . 0.0 111.164 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 1.064 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -123.78 122.59 38.45 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 20' ' ' VAL . 12.3 p -98.01 126.38 51.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.618 ' HB2' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -126.17 125.17 42.03 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.077 0.941 . . . . 0.0 111.155 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB3' HD22 ' A' ' 18' ' ' LEU . 2.1 p90 -132.35 169.71 16.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.886 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -71.66 61.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.38 -44.27 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.665 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 163.41 27.64 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.439 0.638 . . . . 0.0 112.225 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.618 HG22 ' HB2' ' A' ' 66' ' ' TRP . 9.2 pt -126.48 127.66 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.179 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.8 mmt -130.86 144.52 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.18 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -105.21 126.03 51.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.429 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 25.5 mt -124.36 124.7 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.939 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -131.6 147.05 52.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.04 170.98 35.11 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.29 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.386 . . . . 0.0 111.071 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.245 0 N-CA-C 112.881 -0.087 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.847 HD23 ' CE2' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -94.84 90.97 6.22 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.801 0.334 . . . . 0.0 110.593 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.9 ttt -103.41 124.91 49.6 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.772 HG23 HG23 ' A' ' 22' ' ' VAL . 2.8 m -143.77 175.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.4 mt-10 -116.81 122.07 43.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.994 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.5 t -127.03 131.77 70.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.22 117.17 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 122.295 1.045 . . . . 0.0 109.004 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.744 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.3 mp0 -148.35 176.16 10.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.264 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.626 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 1.2 m 88.55 -16.78 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 25' ' ' SER . 20.0 Cg_endo -61.27 -19.51 64.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 121.778 1.671 . . . . 0.0 109.722 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -16.34 61.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.385 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.7 -67.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.432 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -96.63 -136.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.447 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 4.3 tt0 -162.58 104.33 1.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.888 HG12 ' OG1' ' A' ' 49' ' ' THR . 2.5 t -151.45 94.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.093 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.869 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -132.82 114.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -162.55 -172.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 122.682 1.229 . . . . 0.0 110.415 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -79.75 122.4 26.54 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.99 177.46 23.43 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.443 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.02 147.89 32.69 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.003 -1.099 . . . . 0.0 110.173 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.66 ' O ' HD13 ' A' ' 18' ' ' LEU . 33.9 m -123.53 125.31 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' O ' HD13 ' A' ' 45' ' ' LEU . 21.5 t -127.44 130.09 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.877 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -83.78 112.32 19.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.518 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -47.1 -54.18 11.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.2 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 41' ' ' THR . 15.1 m -150.07 44.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.735 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.35 64.05 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.624 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -179.05 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -77.08 138.16 39.38 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -112.18 123.96 51.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.344 -178.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -93.9 123.63 37.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.994 ' CG2' HG21 ' A' ' 22' ' ' VAL . 7.6 mt -128.83 139.69 51.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.211 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 35.2 ttm -123.5 124.41 42.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.888 ' OG1' HG12 ' A' ' 31' ' ' VAL . 71.3 p -97.97 -68.1 0.82 Allowed 'General case' 0 C--N 1.347 0.481 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.456 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.769 ' N ' HG13 ' A' ' 33' ' ' ILE . 8.3 tt0 -174.83 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -70.55 -9.97 58.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 155.36 -179.77 31.09 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.517 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 53' ' ' LEU . 1.9 pt? -126.3 133.37 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.336 -0.432 . . . . 0.0 109.94 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 172.96 11.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 111.653 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 46' ' ' LYS . 31.1 m -103.78 129.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.483 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.744 HG11 ' HG2' ' A' ' 24' ' ' GLU . 16.6 m -133.93 158.51 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.884 0.85 . . . . 0.0 112.396 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 59' ' ' ARG . . . -143.84 176.15 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.348 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -59.12 68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.262 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 57' ' ' ALA . 3.4 mtm180 -143.68 -162.99 1.56 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.822 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 61' ' ' ARG . . . -54.7 113.58 3.64 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.888 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 150.86 163.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.567 0.747 . . . . 0.0 109.081 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -123.95 123.05 39.55 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.974 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.22 140.0 49.79 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.371 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.3 mtt180 -124.57 125.79 44.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 20' ' ' VAL . 16.6 m -123.18 139.13 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.709 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.4 m-90 -124.08 124.78 43.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.855 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.847 ' CE2' HD23 ' A' ' 18' ' ' LEU . 7.3 m-85 -112.0 175.13 5.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.454 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -81.39 59.48 4.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.882 0.372 . . . . 0.0 110.65 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.66 -50.48 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.704 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.78 163.81 31.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.46 129.86 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.37 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.67 147.58 52.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.2 129.32 49.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.12 124.48 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.802 ' HG3' HG23 ' A' ' 62' ' ' THR . 56.4 tttt -125.81 129.45 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.883 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.68 124.59 6.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.32 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.802 0.334 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.651 ' C ' HD12 ' A' ' 18' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.638 -0.185 . . . . 0.0 112.638 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.713 ' HB3' HG23 ' A' ' 37' ' ' VAL . 5.0 mp -113.99 102.75 10.48 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.041 0.448 . . . . 0.0 110.637 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.412 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 30.8 mtt -107.29 123.56 48.5 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.022 HG13 ' O ' ' A' ' 64' ' ' ARG . 97.5 t -132.82 145.22 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.6 tt0 -87.26 122.2 30.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.957 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.2 t -126.49 133.73 68.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -174.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.64 116.83 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.97 176.96 9.75 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.389 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 61.7 114.48 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.639 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.15 10.55 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.541 2.161 . . . . 0.0 111.992 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -43.23 161.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.544 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -30.68 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.673 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.1 t -103.31 -28.54 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 62.0 152.38 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.773 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 ' N ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -115.79 95.69 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.66 115.19 1.55 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.641 ' HB ' ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -159.57 -179.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-O 121.592 0.71 . . . . 0.0 110.464 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 4.4 mtpm? -75.98 121.65 23.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.11 177.22 22.91 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 118.791 -1.671 . . . . 0.0 116.164 -174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.96 145.67 28.37 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 113.87 -1.165 . . . . 0.0 110.72 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' HB3' ' A' ' 18' ' ' LEU . 3.1 m -123.64 127.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.0 t -127.48 132.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.312 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.93 107.87 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.7 91.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m 58.6 31.83 21.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 57.95 65.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.783 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.5 -76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 57' ' ' ALA . 22.9 m -81.87 150.27 27.87 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.04 123.81 51.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.537 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HG2' HG12 ' A' ' 55' ' ' VAL . 7.2 mtpp -113.45 123.1 49.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.957 ' CG2' HG21 ' A' ' 22' ' ' VAL . 5.2 mt -132.05 144.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.102 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.511 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 5.7 ttp -124.02 124.21 42.06 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.1 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.562 ' HB ' ' N ' ' A' ' 33' ' ' ILE . 9.5 p -132.21 -92.94 0.37 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.641 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 3.9 tp10 -89.4 -93.89 0.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.864 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -38.53 -30.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 151.83 -142.73 9.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.393 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.14 128.25 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 111.008 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 148.25 52.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.631 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 46' ' ' LYS . 35.9 m -115.57 126.12 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.347 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' HD3' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -129.39 140.05 50.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.578 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -124.75 124.91 43.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.665 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 58.46 111.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.48 174.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.14 0.495 . . . . 0.0 111.706 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.22 11.81 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.012 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER 170.12 126.27 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.1 m -124.32 123.69 40.76 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.286 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -144.02 174.22 11.05 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.516 0.674 . . . . 0.0 111.84 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 1.022 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -124.44 124.51 42.47 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 67' ' ' TYR . 9.1 p -104.31 141.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 2.0 m-90 -124.45 124.25 41.9 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.75 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 69.5 m-85 -115.28 175.47 5.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.935 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 56.21 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.857 0.361 . . . . 0.0 110.447 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.0 -52.81 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.97 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 165.61 26.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.934 0.397 . . . . 0.0 111.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.29 134.66 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.307 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.9 mmt -140.75 168.47 19.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.995 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -101.99 130.12 48.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 HG21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 tt -124.72 124.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.793 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 140.12 51.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.545 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.31 124.89 9.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 111.173 -179.783 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.379 -0.288 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.668 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.9 mp -95.12 78.24 3.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.807 0.336 . . . . 0.0 110.866 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.39 127.07 49.56 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 37' ' ' VAL . 12.1 m -142.88 175.15 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -121.63 121.31 37.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 63' ' ' PHE . 33.1 t -131.72 143.41 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 -175.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.72 117.98 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.29 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.72 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -148.25 174.63 11.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.992 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.681 ' N ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER 34.5 41.13 0.17 Allowed Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.322 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.72 ' HD3' ' C ' ' A' ' 24' ' ' GLU . 75.8 Cg_endo -99.81 6.33 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.797 2.331 . . . . 0.0 109.519 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.44 -28.31 9.44 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.438 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -44.07 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.17 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' GLU . 1.7 p -125.18 -102.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.226 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 25' ' ' SER . 0.9 OUTLIER 166.86 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 O-C-N 122.401 -0.187 . . . . 0.0 111.444 179.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.977 HG22 ' HB2' ' A' ' 51' ' ' LYS . 1.5 t -130.74 82.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -133.13 114.1 1.34 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.82 HG12 ' C ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -160.89 -175.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 110.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -73.87 121.06 20.32 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 175.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.85 177.57 20.77 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.601 -1.285 . . . . 0.0 115.403 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' HD12 ' A' ' 47' ' ' ILE . 9.6 tt0 -111.4 144.39 40.69 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 113.935 -1.132 . . . . 0.0 111.016 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.834 ' CG1' HD13 ' A' ' 47' ' ' ILE . 27.8 m -123.99 125.89 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.505 0.669 . . . . 0.0 112.535 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 m -128.28 136.7 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.366 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.04 107.4 17.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.15 95.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m 54.47 32.77 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.05 69.97 0.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.29 -80.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 57' ' ' ALA . 1.4 m -85.97 160.18 19.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -107.95 124.13 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.07 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.709 ' HE2' HD23 ' A' ' 53' ' ' LEU . 6.8 tttt -110.26 124.23 51.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.834 HD13 ' CG1' ' A' ' 37' ' ' VAL . 3.0 tp -127.14 135.94 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.24 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.609 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -122.35 124.32 43.43 Favored 'General case' 0 C--O 1.251 1.141 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.885 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.82 ' C ' HG12 ' A' ' 33' ' ' ILE . 81.4 p -135.18 -104.02 0.22 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.129 0.893 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.71 -85.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.977 ' HB2' HG22 ' A' ' 31' ' ' VAL . 1.7 tttp -43.55 -28.5 0.38 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.58 -131.68 5.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.869 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD23 ' HE2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -99.13 125.45 44.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.124 0.487 . . . . 0.0 111.625 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 137.43 52.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.177 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 46' ' ' LYS . 15.4 m -109.0 128.15 65.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.669 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.9 t -128.37 137.97 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.111 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -126.25 131.92 51.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.676 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 62.2 75.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.42 -179.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.318 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' CZ ' ' A' ' 63' ' ' PHE . . . 126.64 122.58 2.57 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.138 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 13.9 mmt180 68.33 -172.98 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.708 0.254 . . . . 0.0 110.456 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.7 m -124.26 124.15 41.79 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.298 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.77 153.7 51.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.247 0.546 . . . . 0.0 111.684 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.691 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 1.7 mtm-85 -123.96 124.91 43.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 20' ' ' VAL . 58.0 t -115.31 138.43 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.65 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m-90 -124.11 124.6 42.87 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.858 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE1' HG11 ' A' ' 65' ' ' VAL . 83.4 m-85 -110.35 175.3 5.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.182 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 58.48 2.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.415 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.0 -56.21 0.14 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.985 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -132.75 164.58 26.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.519 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.35 129.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mtp -136.02 158.08 45.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.024 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.48 55.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.621 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' A' ' 63' ' ' PHE . 7.0 tp -127.0 133.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.235 0.541 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 145.93 52.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.36 145.96 27.12 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.603 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.979 -0.048 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG23 ' A' ' 37' ' ' VAL . 4.4 mp -92.88 101.64 14.0 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.745 0.307 . . . . 0.0 110.341 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.05 126.34 51.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.868 ' CG1' HG13 ' A' ' 65' ' ' VAL . 5.9 m -144.0 175.36 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.7 mm-40 -118.72 121.34 39.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 47' ' ' ILE . 14.3 t -130.66 140.9 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.5 118.32 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.864 174.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -146.7 176.3 9.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.162 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.645 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 64.36 104.53 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.26 -5.19 13.21 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.554 2.169 . . . . 0.0 112.106 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -38.76 157.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.907 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -50.89 -51.84 47.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -79.53 -34.33 41.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.726 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 31' ' ' VAL . 3.2 tt0 62.58 149.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 49' ' ' THR . 8.7 p -111.05 93.26 2.4 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.186 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' CG2' ' A' ' 33' ' ' ILE . . . -135.25 114.61 1.26 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.681 HG12 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -163.22 -173.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.622 -0.928 . . . . 0.0 109.841 178.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.26 122.22 21.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 176.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.04 177.35 22.78 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.277 -0.963 . . . . 0.0 114.748 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.65 148.9 31.28 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.397 -0.902 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.676 HG21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -128.32 138.68 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.591 0.71 . . . . 0.0 112.666 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.53 131.48 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.1 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.805 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 24.4 m-20 72.16 74.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.815 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HG2' HD21 ' A' ' 45' ' ' LEU . 2.8 tm-20 -88.53 -64.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.416 HG23 ' OE1' ' A' ' 40' ' ' GLU . 14.5 p -103.21 24.75 10.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -99.8 -78.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.637 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -137.08 -106.03 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.253 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 p -82.64 151.8 26.15 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -107.96 124.13 49.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.288 -179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.888 ' CG ' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -108.87 123.65 49.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.922 HD11 HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.95 129.39 72.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.504 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.79 ' HB3' HD13 ' A' ' 53' ' ' LEU . 28.2 ptm -123.8 124.54 42.91 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.388 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 1.011 ' OG1' HG22 ' A' ' 31' ' ' VAL . 3.1 p -112.25 -90.87 0.49 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.681 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -129.57 -58.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.449 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.796 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.4 tptp -55.02 -16.3 2.71 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.636 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.53 -162.28 29.02 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.077 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 48' ' ' MET . 14.2 tp -121.84 124.81 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.348 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 154.24 38.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG12 ' CG ' ' A' ' 46' ' ' LYS . 34.9 m -114.26 127.72 71.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.341 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -143.71 175.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.322 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.544 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -113.83 175.23 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.206 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -68.79 67.7 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.124 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.5 72.68 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' CZ ' ' A' ' 63' ' ' PHE . . . 160.24 144.92 4.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.329 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER 58.37 -177.39 0.08 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.3 m -124.83 124.16 41.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.862 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -131.84 147.26 52.47 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.0 0.429 . . . . 0.0 111.296 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -124.38 124.74 43.0 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG13 ' CG1' ' A' ' 20' ' ' VAL . 25.3 t -119.39 139.93 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.663 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.6 m-90 -123.54 124.79 43.61 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.748 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -123.43 175.57 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.998 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.73 7.11 9.17 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.14 -32.85 1.44 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.734 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -175.35 0.28 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.627 0.251 . . . . 0.0 110.768 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -124.17 135.58 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.315 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mmt -135.43 156.86 48.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -126.85 134.31 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.017 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 74' ' ' ILE . 5.9 tp -124.01 124.66 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 129.72 49.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -119.36 160.25 14.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.341 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -97.15 113.09 24.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 ttt -104.68 127.43 52.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.854 HG23 HG23 ' A' ' 22' ' ' VAL . 2.3 m -143.75 175.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 4.3 tt0 -120.08 122.23 40.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.997 HG21 ' CG2' ' A' ' 47' ' ' ILE . 39.7 t -130.4 142.15 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.55 118.84 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.873 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 6.3 pt-20 -146.22 176.0 10.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.274 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.76 ' OG ' HG23 ' A' ' 31' ' ' VAL . 99.6 p 54.57 102.58 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.659 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.22 -2.9 11.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.39 2.06 . . . . 0.0 111.72 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -35.16 155.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.386 0.674 . . . . 0.0 112.113 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -47.58 -35.18 8.76 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.173 0.511 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 1.8 p -113.43 66.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.458 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -37.56 147.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.84 HG12 ' OG1' ' A' ' 49' ' ' THR . 6.3 t -105.96 85.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -134.26 114.94 1.38 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.72 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -161.57 -174.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-O 121.848 0.832 . . . . 0.0 109.915 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 82.3 mttt -71.36 122.01 19.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.59 177.65 22.24 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.622 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -110.01 149.52 29.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.114 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.849 HG12 HG23 ' A' ' 47' ' ' ILE . 29.8 m -122.31 124.96 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.37 0.605 . . . . 0.0 112.515 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.75 HG23 ' HG3' ' A' ' 46' ' ' LYS . 13.7 m -129.19 137.93 55.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.385 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 118.18 26.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.671 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 41' ' ' THR . 4.6 tt0 -57.77 99.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.997 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 40' ' ' GLU . 14.0 t 44.63 38.34 2.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.383 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 59.02 68.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -166.64 -79.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.59 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.809 HG23 ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -87.23 163.3 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.929 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -111.39 124.28 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.811 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -120.99 124.71 45.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.948 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.997 ' CG2' HG21 ' A' ' 22' ' ' VAL . 1.7 mp -127.85 137.87 56.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.102 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.436 ' HB3' ' CB ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.91 129.59 50.69 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.254 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.84 ' OG1' HG12 ' A' ' 31' ' ' VAL . 20.7 p -106.05 -93.64 0.37 Allowed 'General case' 0 C--N 1.352 0.675 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.575 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.712 ' CB ' HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 -58.35 0.91 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 122.327 -0.233 . . . . 0.0 111.591 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.838 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.28 -18.08 14.89 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.647 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.535 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 157.69 -163.53 32.68 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.517 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.3 pt? -128.1 139.16 52.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.954 0.407 . . . . 0.0 110.771 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -124.78 145.2 49.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.694 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' ' 46' ' ' LYS . 33.9 m -123.04 127.61 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.179 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 44' ' ' THR . 10.6 p -138.55 163.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.216 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -129.07 141.62 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.767 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.57 -68.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.234 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.1 156.66 41.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 0.0 111.405 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.552 ' HA3' HG21 ' A' ' 56' ' ' VAL . . . 154.71 124.48 0.92 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.533 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.476 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 6.1 mmp_? 63.89 -175.8 0.16 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.3 m -124.28 123.58 40.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.796 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -135.7 154.03 51.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.557 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.811 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 mtp180 -125.4 127.52 46.69 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG12 HG11 ' A' ' 20' ' ' VAL . 16.0 m -119.0 140.13 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.7 m-90 -125.61 128.43 47.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.126 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.737 ' CD1' HD13 ' A' ' 18' ' ' LEU . 35.4 t80 -126.8 163.03 24.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.516 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.03 65.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.76 -43.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.613 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -160.72 170.64 20.37 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -127.62 135.7 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.276 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 mtt -136.69 160.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -123.1 134.43 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.71 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.1 mt -123.78 124.64 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.651 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.95 126.81 46.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 125.34 6.9 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.615 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.645 ' HB3' HG13 ' A' ' 37' ' ' VAL . 9.3 mt . . . . . 0 C--O 1.246 0.873 0 CA-C-O 120.548 0.213 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.435 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 5.1 ttt -100.32 123.6 44.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 64' ' ' ARG . 6.7 p -136.9 153.31 29.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HB2' ' HH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -107.58 122.49 46.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 174.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 47' ' ' ILE . 17.7 t -128.93 138.24 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 62' ' ' THR . 2.7 m -123.37 117.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.3 mt-10 -147.4 177.24 9.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.666 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 31' ' ' VAL . 9.7 m . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.325 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 51' ' ' LYS . 3.3 t . . . . . 0 C--O 1.245 0.866 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.3 115.61 1.67 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.65 -179.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 121.963 0.887 . . . . 0.0 111.229 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.664 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.9 mttt -75.77 121.59 22.79 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.45 177.63 22.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.133 -175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.95 149.48 27.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.319 -0.941 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.731 HG12 HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -118.57 144.81 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 122.672 1.225 . . . . 0.0 113.424 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 C--N 1.315 -0.908 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.796 178.463 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.468 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mt -118.37 124.06 46.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -121.22 124.24 44.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -130.88 143.62 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.62 -179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.463 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 4.4 ttm -123.94 126.49 46.44 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.269 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 6.0 p -103.4 -88.75 0.4 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.181 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -141.16 -53.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.348 -0.22 . . . . 0.0 110.934 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.673 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.4 tptm -61.55 -14.79 32.67 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 154.47 -166.85 32.36 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.762 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.0 pt? -124.31 134.57 53.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.29 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 147.24 49.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.153 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 46' ' ' LYS . 22.8 m -119.24 125.88 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.721 -179.816 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.401 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 23' ' ' VAL . 91.9 m -124.18 122.8 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.542 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.7 p90 -134.77 149.44 50.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 1.024 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 ptp180 -124.52 123.77 40.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.34 141.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.56 ' HH2' ' HB2' ' A' ' 21' ' ' GLU . 2.9 m-90 -124.64 124.78 42.94 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.225 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' CE1' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.13 175.68 5.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.995 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 5.19 7.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.609 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.84 -52.29 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.87 -178.3 7.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.5 pp -125.73 131.38 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.261 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 74' ' ' ILE . 7.7 ttp -134.43 154.66 51.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.997 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 74' ' ' ILE . 44.4 mtt85 -123.2 130.39 52.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.704 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.435 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 29.2 mm -124.01 124.64 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.1 tttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 179.505 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.4 mp . . . . . 0 C--O 1.246 0.898 0 CA-C-O 120.795 0.331 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.68 127.49 53.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.827 HG23 HG23 ' A' ' 22' ' ' VAL . 2.9 m -143.59 175.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 3.2 tt0 -119.6 122.83 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.916 HG21 ' CG2' ' A' ' 47' ' ' ILE . 47.9 t -131.01 145.29 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.66 119.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.538 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.503 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . 6.0 pt-20 -146.63 176.3 9.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.754 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.402 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.729 HG12 ' OG1' ' A' ' 49' ' ' THR . 18.2 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.6 115.21 1.56 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.669 HG13 ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -160.79 -178.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 O-C-N 121.78 -0.835 . . . . 0.0 111.113 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' N ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmtp -74.41 121.66 21.76 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.58 177.68 22.97 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.971 -1.109 . . . . 0.0 114.853 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -110.26 149.41 30.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.431 -0.885 . . . . 0.0 111.006 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.927 HG12 HG23 ' A' ' 47' ' ' ILE . 32.6 m -120.88 124.23 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.698 0.761 . . . . 0.0 112.428 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 22.0 t . . . . . 0 N--CA 1.444 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.538 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.07 124.36 51.34 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.622 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB3' HG12 ' A' ' 55' ' ' VAL . 3.5 pttp -115.24 124.38 51.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 37' ' ' VAL . 2.8 mt -127.75 136.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.443 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.31 128.18 49.58 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.665 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.729 ' OG1' HG12 ' A' ' 31' ' ' VAL . 4.2 p -107.09 -88.22 0.47 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.249 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HB2' HG13 ' A' ' 33' ' ' ILE . 1.1 mt-10 -138.63 -55.61 0.62 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 122.35 -0.219 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.711 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.66 -16.77 11.67 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.358 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 153.32 -163.14 30.54 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.304 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.1 pt? -127.23 136.59 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.388 . . . . 0.0 110.389 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -126.88 147.44 50.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.797 HG12 ' HB3' ' A' ' 46' ' ' LYS . 28.1 m -120.31 128.04 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.514 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CB ' ' A' ' 24' ' ' GLU . 5.9 mmp_? . . . . . 0 C--O 1.238 0.477 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.493 HG23 ' CB ' ' A' ' 75' ' ' LYS . 4.7 m -123.65 122.76 38.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.617 ' HD1' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -136.6 156.1 49.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.339 0.59 . . . . 0.0 111.934 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.734 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 16.5 mtt180 -124.89 125.04 43.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 20' ' ' VAL . 19.9 m -117.8 138.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.6 m-90 -124.27 124.78 43.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.601 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -127.26 164.0 22.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -69.44 66.42 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.69 -35.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.425 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.26 168.21 5.68 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 111.481 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.9 127.88 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.59 159.43 41.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.822 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.83 128.73 49.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 63' ' ' PHE . 1.5 tp -124.48 124.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.432 . . . . 0.0 111.303 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' CB ' HG23 ' A' ' 62' ' ' THR . 11.0 pttt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.483 ' HB2' HG23 ' A' ' 37' ' ' VAL . 4.9 mp . . . . . 0 C--O 1.245 0.862 0 CA-C-O 120.731 0.3 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.9 mtt -103.99 123.07 46.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 64' ' ' ARG . 98.4 t -134.94 146.79 29.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' CB ' ' CH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -96.24 122.2 38.85 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 174.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.97 ' CG2' HG21 ' A' ' 47' ' ' ILE . 12.1 t -128.85 137.24 57.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' THR . 3.6 m -123.16 117.01 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB3' ' CD ' ' A' ' 61' ' ' ARG . 16.1 pt-20 -148.5 177.25 9.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.257 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.876 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 51' ' ' LYS . 2.9 t . . . . . 0 C--O 1.249 1.039 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.31 115.09 1.57 Allowed Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.637 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -159.18 -179.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.894 0.854 . . . . 0.0 110.698 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.637 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.8 mttp -76.39 121.35 22.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.84 177.61 22.45 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.416 -1.373 . . . . 0.0 115.427 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.62 148.52 29.22 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.293 -0.953 . . . . 0.0 111.094 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 20' ' ' VAL . 33.9 m -122.44 124.25 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.683 0.754 . . . . 0.0 112.836 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 m . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.073 178.319 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.252 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.62 124.19 51.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.041 -0.663 . . . . 0.0 111.571 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.772 ' HE2' HD23 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -113.41 124.33 52.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.97 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.4 mp -128.9 140.77 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.54 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.505 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 3.9 ppp? -119.68 124.36 46.07 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.888 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.584 HG21 ' HB ' ' A' ' 22' ' ' VAL . 23.0 p -131.23 -92.72 0.41 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.568 0.543 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.635 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tt0 -90.39 -91.28 0.14 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.902 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -41.48 -29.68 0.17 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.46 -135.61 5.87 Favored Glycine 0 C--O 1.241 0.557 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.257 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.772 HD23 ' HE2' ' A' ' 46' ' ' LYS . 6.4 mp -100.37 124.96 46.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.192 0.52 . . . . 0.0 111.998 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -128.49 138.11 52.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.947 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' CG ' ' A' ' 46' ' ' LYS . 29.8 m -111.95 127.07 69.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.284 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.54 0 CA-C-O 120.893 0.378 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 23' ' ' VAL . 40.0 m -124.03 123.17 39.78 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 22' ' ' VAL . 3.4 p90 -139.14 162.39 35.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.458 0.646 . . . . 0.0 111.965 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 1.035 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -124.59 123.67 40.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 20' ' ' VAL . 11.8 p -108.84 139.26 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.484 ' CH2' ' CB ' ' A' ' 21' ' ' GLU . 1.9 m-90 -124.03 124.21 42.04 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.919 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 4.2 t80 -120.23 159.19 25.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.952 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.33 66.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 67' ' ' TYR . . . 170.79 -50.39 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.699 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.32 166.97 27.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.04 137.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.4 tpp -136.76 160.1 39.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.76 128.93 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.594 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.498 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.5 mp -124.09 124.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.042 0.449 . . . . 0.0 111.577 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.8 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.939 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.5 mp . . . . . 0 C--O 1.245 0.853 0 CA-C-O 120.702 0.286 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.453 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -104.49 123.63 47.84 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.99 HG11 HG13 ' A' ' 37' ' ' VAL . 8.1 p -134.32 146.8 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.6 mt-10 -100.18 121.51 41.56 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.774 HG21 HG12 ' A' ' 47' ' ' ILE . 43.9 t -133.41 146.84 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -124.55 118.59 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.197 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 4.1 mt-10 -147.1 177.06 9.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.482 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.709 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.587 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.897 HG22 ' OG1' ' A' ' 49' ' ' THR . 13.0 p . . . . . 0 C--O 1.247 0.937 0 CA-C-O 121.307 0.575 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.634 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -133.33 115.71 1.59 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -160.3 -179.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.521 -0.988 . . . . 0.0 111.415 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.651 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -76.69 121.28 23.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.37 177.76 22.75 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.924 -1.131 . . . . 0.0 114.662 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -109.42 146.5 34.37 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.617 -0.791 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.99 HG13 HG11 ' A' ' 20' ' ' VAL . 1.6 m -124.19 125.87 71.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.379 0.609 . . . . 0.0 111.805 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.647 179.418 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.01 124.77 52.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.818 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.37 124.39 49.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.774 HG12 HG21 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -122.61 130.49 74.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.392 -178.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.648 ' N ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -123.22 124.74 43.69 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.897 ' OG1' HG22 ' A' ' 31' ' ' VAL . 1.6 p -109.27 -89.22 0.48 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.909 -0.717 . . . . 0.0 111.325 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' ILE . 37.0 tt0 -130.43 -59.86 1.01 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.172 -0.33 . . . . 0.0 111.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.807 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.27 -8.01 1.49 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.76 -166.4 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.2 pt? -127.89 138.13 52.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.15 149.1 52.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.377 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' A' ' 46' ' ' LYS . 30.3 m -112.21 127.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 111.139 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG21 ' OE2' ' A' ' 24' ' ' GLU . 2.9 m . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.56 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 5.8 mmp_? . . . . . 0 C--O 1.236 0.377 0 CA-C-O 120.457 0.17 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.4 m -124.26 122.87 38.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.119 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 p90 -135.51 151.74 50.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.9 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 mmt180 -124.37 123.84 41.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG11 ' OH ' ' A' ' 67' ' ' TYR . 10.8 p -118.82 146.41 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 1.6 m-90 -124.54 124.62 42.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.454 -1.703 . . . . 0.0 110.321 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' OH ' HG11 ' A' ' 65' ' ' VAL . 3.6 m-85 -110.89 175.39 5.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.123 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -73.92 61.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.631 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.72 -67.67 0.18 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.0 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -124.05 168.73 12.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.048 0.452 . . . . 0.0 111.528 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.5 pt -128.57 139.36 52.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.325 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.03 160.76 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.51 130.2 52.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -123.95 124.76 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.599 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.525 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.838 0 CA-C-O 120.785 0.326 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.562 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 16.8 mtp -109.92 124.62 51.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 64' ' ' ARG . 81.9 t -130.12 141.3 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.907 -0.495 . . . . 0.0 111.876 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' OE2' ' CE3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -88.51 121.09 30.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 175.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.995 ' CG2' HG21 ' A' ' 47' ' ' ILE . 17.7 t -129.37 137.83 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -174.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.09 118.07 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.519 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 5.5 mt-10 -146.61 176.21 10.01 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.252 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 31' ' ' VAL . 1.4 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.339 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.875 HG22 ' OG1' ' A' ' 49' ' ' THR . 2.7 p . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -133.33 114.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.733 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -160.43 -175.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 O-C-N 121.625 -0.927 . . . . 0.0 110.214 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 4.0 mmpt? -76.05 120.78 21.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.56 176.37 19.94 Favored Glycine 0 CA--C 1.501 -0.811 0 C-N-CA 119.579 -1.295 . . . . 0.0 115.054 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 145.3 31.6 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.502 -0.849 . . . . 0.0 111.633 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.77 HG11 HG21 ' A' ' 20' ' ' VAL . 19.0 m -123.22 124.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.594 178.056 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.231 0.12 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.9 124.37 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.332 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.634 ' CG ' HG12 ' A' ' 55' ' ' VAL . 6.9 ttpt -116.7 124.31 49.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.995 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.9 mp -130.34 143.87 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.519 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.473 ' HG3' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -124.72 129.8 51.19 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.044 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.875 ' OG1' HG22 ' A' ' 31' ' ' VAL . 4.4 p -134.77 -114.62 0.2 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 123.803 0.689 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.788 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.19 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' CB ' ' HB ' ' A' ' 31' ' ' VAL . 1.3 tttm -44.15 -57.99 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.2 -135.68 2.62 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.724 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD23 ' CG ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -103.07 127.43 50.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.046 -0.577 . . . . 0.0 112.238 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -128.33 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.763 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.634 HG12 ' CG ' ' A' ' 46' ' ' LYS . 27.2 m -118.23 127.26 75.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 112.115 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.659 179.149 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' N ' ' NE ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.516 0.198 . . . . 0.0 110.931 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -123.96 123.06 39.56 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.612 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 p90 -133.71 147.15 51.34 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.944 0.402 . . . . 0.0 111.164 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 1.064 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -123.78 122.59 38.45 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 20' ' ' VAL . 12.3 p -98.01 126.38 51.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.618 ' HB2' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -126.17 125.17 42.03 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.077 0.941 . . . . 0.0 111.155 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB3' HD22 ' A' ' 18' ' ' LEU . 2.1 p90 -132.35 169.71 16.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.886 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -71.66 61.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.38 -44.27 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.665 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 163.41 27.64 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.439 0.638 . . . . 0.0 112.225 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.618 HG22 ' HB2' ' A' ' 66' ' ' TRP . 9.2 pt -126.48 127.66 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.179 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.8 mmt -130.86 144.52 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.18 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -105.21 126.03 51.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.429 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 25.5 mt -124.36 124.7 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.939 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.847 HD23 ' CE2' ' A' ' 67' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.846 0 CA-C-O 120.801 0.334 . . . . 0.0 110.593 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.9 ttt -103.41 124.91 49.6 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.772 HG23 HG23 ' A' ' 22' ' ' VAL . 2.8 m -143.77 175.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.4 mt-10 -116.81 122.07 43.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.994 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.5 t -127.03 131.77 70.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.22 117.17 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 122.295 1.045 . . . . 0.0 109.004 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.744 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.3 mp0 -148.35 176.16 10.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.264 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.2 m . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.888 HG12 ' OG1' ' A' ' 49' ' ' THR . 2.5 t . . . . . 0 C--O 1.249 1.038 0 CA-C-O 120.963 0.411 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.869 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -132.82 114.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -162.55 -172.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 122.682 1.229 . . . . 0.0 110.415 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -79.75 122.4 26.54 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.99 177.46 23.43 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.443 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.02 147.89 32.69 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.003 -1.099 . . . . 0.0 110.173 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.66 ' O ' HD13 ' A' ' 18' ' ' LEU . 33.9 m -123.53 125.31 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' O ' HD13 ' A' ' 45' ' ' LEU . 21.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.877 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -112.18 123.96 51.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.344 -178.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -93.9 123.63 37.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.994 ' CG2' HG21 ' A' ' 22' ' ' VAL . 7.6 mt -128.83 139.69 51.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.211 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 35.2 ttm -123.5 124.41 42.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.888 ' OG1' HG12 ' A' ' 31' ' ' VAL . 71.3 p -97.97 -68.1 0.82 Allowed 'General case' 0 C--N 1.347 0.481 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.456 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.769 ' N ' HG13 ' A' ' 33' ' ' ILE . 8.3 tt0 -174.83 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -70.55 -9.97 58.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 155.36 -179.77 31.09 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.517 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 53' ' ' LEU . 1.9 pt? -126.3 133.37 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.336 -0.432 . . . . 0.0 109.94 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 172.96 11.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 111.653 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 46' ' ' LYS . 31.1 m -103.78 129.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.483 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.744 HG11 ' HG2' ' A' ' 24' ' ' GLU . 16.6 m . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.884 0.85 . . . . 0.0 112.396 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -123.95 123.05 39.55 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.974 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.22 140.0 49.79 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.371 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.3 mtt180 -124.57 125.79 44.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 20' ' ' VAL . 16.6 m -123.18 139.13 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.709 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.4 m-90 -124.08 124.78 43.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.855 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.847 ' CE2' HD23 ' A' ' 18' ' ' LEU . 7.3 m-85 -112.0 175.13 5.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.454 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -81.39 59.48 4.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.882 0.372 . . . . 0.0 110.65 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.66 -50.48 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.704 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.78 163.81 31.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.46 129.86 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.37 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.67 147.58 52.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.2 129.32 49.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.12 124.48 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.802 ' HG3' HG23 ' A' ' 62' ' ' THR . 56.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.883 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.713 ' HB3' HG23 ' A' ' 37' ' ' VAL . 5.0 mp . . . . . 0 C--O 1.244 0.795 0 CA-C-O 121.041 0.448 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.412 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 30.8 mtt -107.29 123.56 48.5 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.022 HG13 ' O ' ' A' ' 64' ' ' ARG . 97.5 t -132.82 145.22 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.6 tt0 -87.26 122.2 30.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.957 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.2 t -126.49 133.73 68.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -174.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.64 116.83 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.97 176.96 9.75 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.389 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.639 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 ' N ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.935 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.66 115.19 1.55 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.641 ' HB ' ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -159.57 -179.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-O 121.592 0.71 . . . . 0.0 110.464 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 4.4 mtpm? -75.98 121.65 23.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.11 177.22 22.91 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 118.791 -1.671 . . . . 0.0 116.164 -174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.96 145.67 28.37 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 113.87 -1.165 . . . . 0.0 110.72 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' HB3' ' A' ' 18' ' ' LEU . 3.1 m -123.64 127.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.312 178.323 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 m . . . . . 0 CA--C 1.518 -0.25 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.04 123.81 51.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.537 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HG2' HG12 ' A' ' 55' ' ' VAL . 7.2 mtpp -113.45 123.1 49.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.957 ' CG2' HG21 ' A' ' 22' ' ' VAL . 5.2 mt -132.05 144.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.102 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.511 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 5.7 ttp -124.02 124.21 42.06 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.1 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.562 ' HB ' ' N ' ' A' ' 33' ' ' ILE . 9.5 p -132.21 -92.94 0.37 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.641 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 3.9 tp10 -89.4 -93.89 0.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.864 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -38.53 -30.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 151.83 -142.73 9.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.393 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.14 128.25 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 111.008 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 148.25 52.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.631 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 46' ' ' LYS . 35.9 m -115.57 126.12 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.347 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' HD3' ' A' ' 61' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.578 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.1 m -124.32 123.69 40.76 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.286 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -144.02 174.22 11.05 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.516 0.674 . . . . 0.0 111.84 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 1.022 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -124.44 124.51 42.47 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 67' ' ' TYR . 9.1 p -104.31 141.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 2.0 m-90 -124.45 124.25 41.9 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.75 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 69.5 m-85 -115.28 175.47 5.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.935 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 56.21 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.857 0.361 . . . . 0.0 110.447 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.0 -52.81 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.97 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 165.61 26.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.934 0.397 . . . . 0.0 111.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.29 134.66 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.307 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.9 mmt -140.75 168.47 19.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.995 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -101.99 130.12 48.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 HG21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 tt -124.72 124.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.793 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.545 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.668 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.9 mp . . . . . 0 C--O 1.245 0.848 0 CA-C-O 120.807 0.336 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.39 127.07 49.56 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 37' ' ' VAL . 12.1 m -142.88 175.15 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -121.63 121.31 37.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 63' ' ' PHE . 33.1 t -131.72 143.41 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 -175.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.72 117.98 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.29 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -148.25 174.63 11.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.992 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.611 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.322 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.977 HG22 ' HB2' ' A' ' 51' ' ' LYS . 1.5 t . . . . . 0 C--O 1.248 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -133.13 114.1 1.34 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.82 HG12 ' C ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -160.89 -175.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 110.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -73.87 121.06 20.32 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 175.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.85 177.57 20.77 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.601 -1.285 . . . . 0.0 115.403 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' HD12 ' A' ' 47' ' ' ILE . 9.6 tt0 -111.4 144.39 40.69 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 113.935 -1.132 . . . . 0.0 111.016 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.834 ' CG1' HD13 ' A' ' 47' ' ' ILE . 27.8 m -123.99 125.89 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.505 0.669 . . . . 0.0 112.535 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.366 178.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.52 -0.174 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -107.95 124.13 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.07 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.709 ' HE2' HD23 ' A' ' 53' ' ' LEU . 6.8 tttt -110.26 124.23 51.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.834 HD13 ' CG1' ' A' ' 37' ' ' VAL . 3.0 tp -127.14 135.94 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.24 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.609 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -122.35 124.32 43.43 Favored 'General case' 0 C--O 1.251 1.141 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.885 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.82 ' C ' HG12 ' A' ' 33' ' ' ILE . 81.4 p -135.18 -104.02 0.22 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.129 0.893 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.71 -85.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.977 ' HB2' HG22 ' A' ' 31' ' ' VAL . 1.7 tttp -43.55 -28.5 0.38 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.58 -131.68 5.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.869 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.709 HD23 ' HE2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -99.13 125.45 44.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.124 0.487 . . . . 0.0 111.625 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 137.43 52.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.177 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 46' ' ' LYS . 15.4 m -109.0 128.15 65.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.669 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.111 179.712 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 13.9 mmt180 . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.7 m -124.26 124.15 41.79 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.298 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.77 153.7 51.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.247 0.546 . . . . 0.0 111.684 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.691 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 1.7 mtm-85 -123.96 124.91 43.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 20' ' ' VAL . 58.0 t -115.31 138.43 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.65 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m-90 -124.11 124.6 42.87 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.858 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE1' HG11 ' A' ' 65' ' ' VAL . 83.4 m-85 -110.35 175.3 5.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.182 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 58.48 2.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.415 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.0 -56.21 0.14 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.985 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -132.75 164.58 26.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.519 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.35 129.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mtp -136.02 158.08 45.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.024 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.48 55.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.621 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' A' ' 63' ' ' PHE . 7.0 tp -127.0 133.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.235 0.541 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.693 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG23 ' A' ' 37' ' ' VAL . 4.4 mp . . . . . 0 C--O 1.247 0.935 0 CA-C-O 120.745 0.307 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.05 126.34 51.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.868 ' CG1' HG13 ' A' ' 65' ' ' VAL . 5.9 m -144.0 175.36 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.7 mm-40 -118.72 121.34 39.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 47' ' ' ILE . 14.3 t -130.66 140.9 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.5 118.32 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.864 174.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -146.7 176.3 9.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.162 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.645 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 49' ' ' THR . 8.7 p . . . . . 0 C--O 1.248 1.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.186 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' CG2' ' A' ' 33' ' ' ILE . . . -135.25 114.61 1.26 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.681 HG12 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -163.22 -173.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.622 -0.928 . . . . 0.0 109.841 178.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.26 122.22 21.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 176.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.04 177.35 22.78 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.277 -0.963 . . . . 0.0 114.748 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.65 148.9 31.28 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.397 -0.902 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.676 HG21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -128.32 138.68 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.591 0.71 . . . . 0.0 112.666 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.1 179.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.96 124.13 49.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.288 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.888 ' CG ' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -108.87 123.65 49.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.922 HD11 HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.95 129.39 72.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.504 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.79 ' HB3' HD13 ' A' ' 53' ' ' LEU . 28.2 ptm -123.8 124.54 42.91 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.388 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 1.011 ' OG1' HG22 ' A' ' 31' ' ' VAL . 3.1 p -112.25 -90.87 0.49 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.681 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -129.57 -58.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.449 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.796 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.4 tptp -55.02 -16.3 2.71 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.636 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.53 -162.28 29.02 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.077 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 48' ' ' MET . 14.2 tp -121.84 124.81 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.348 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 154.24 38.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.888 HG12 ' CG ' ' A' ' 46' ' ' LYS . 34.9 m -114.26 127.72 71.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.341 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG11 HH11 ' A' ' 61' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.322 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.3 m -124.83 124.16 41.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.862 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -131.84 147.26 52.47 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.0 0.429 . . . . 0.0 111.296 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -124.38 124.74 43.0 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG13 ' CG1' ' A' ' 20' ' ' VAL . 25.3 t -119.39 139.93 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.663 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.6 m-90 -123.54 124.79 43.61 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.748 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -123.43 175.57 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.998 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.73 7.11 9.17 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.14 -32.85 1.44 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.734 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -175.35 0.28 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.627 0.251 . . . . 0.0 110.768 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -124.17 135.58 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.315 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mmt -135.43 156.86 48.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -126.85 134.31 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.017 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 74' ' ' ILE . 5.9 tp -124.01 124.66 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.986 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--O 1.246 0.912 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 ttt -104.68 127.43 52.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.854 HG23 HG23 ' A' ' 22' ' ' VAL . 2.3 m -143.75 175.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 4.3 tt0 -120.08 122.23 40.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.997 HG21 ' CG2' ' A' ' 47' ' ' ILE . 39.7 t -130.4 142.15 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.55 118.84 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.873 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 6.3 pt-20 -146.22 176.0 10.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.274 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.76 ' OG ' HG23 ' A' ' 31' ' ' VAL . 99.6 p . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.659 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.84 HG12 ' OG1' ' A' ' 49' ' ' THR . 6.3 t . . . . . 0 C--O 1.25 1.081 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -134.26 114.94 1.38 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.72 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -161.57 -174.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-O 121.848 0.832 . . . . 0.0 109.915 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 82.3 mttt -71.36 122.01 19.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.59 177.65 22.24 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.622 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -110.01 149.52 29.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.114 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.849 HG12 HG23 ' A' ' 47' ' ' ILE . 29.8 m -122.31 124.96 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.37 0.605 . . . . 0.0 112.515 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.75 HG23 ' HG3' ' A' ' 46' ' ' LYS . 13.7 m . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.385 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.52 -0.187 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -111.39 124.28 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.811 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -120.99 124.71 45.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.948 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.997 ' CG2' HG21 ' A' ' 22' ' ' VAL . 1.7 mp -127.85 137.87 56.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.102 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.436 ' HB3' ' CB ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.91 129.59 50.69 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.254 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.84 ' OG1' HG12 ' A' ' 31' ' ' VAL . 20.7 p -106.05 -93.64 0.37 Allowed 'General case' 0 C--N 1.352 0.675 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.575 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.712 ' CB ' HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 -58.35 0.91 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 122.327 -0.233 . . . . 0.0 111.591 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.838 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.28 -18.08 14.89 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.647 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.535 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 157.69 -163.53 32.68 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.517 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.3 pt? -128.1 139.16 52.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.954 0.407 . . . . 0.0 110.771 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -124.78 145.2 49.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.694 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' ' 46' ' ' LYS . 33.9 m -123.04 127.61 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.179 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 44' ' ' THR . 10.6 p . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.216 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.476 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 6.1 mmp_? . . . . . 0 C--O 1.235 0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.3 m -124.28 123.58 40.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.796 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -135.7 154.03 51.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.557 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.811 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 mtp180 -125.4 127.52 46.69 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG12 HG11 ' A' ' 20' ' ' VAL . 16.0 m -119.0 140.13 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.7 m-90 -125.61 128.43 47.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.126 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.737 ' CD1' HD13 ' A' ' 18' ' ' LEU . 35.4 t80 -126.8 163.03 24.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.516 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.03 65.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.76 -43.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.613 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -160.72 170.64 20.37 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -127.62 135.7 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.276 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 mtt -136.69 160.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -123.1 134.43 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.71 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.1 mt -123.78 124.64 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.651 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.564 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.199 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.645 ' HB3' HG13 ' A' ' 37' ' ' VAL . 9.3 mt -71.19 75.61 0.7 Allowed 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.548 0.213 . . . . 0.0 111.133 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.435 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 5.1 ttt -100.32 123.6 44.75 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.024 HG23 ' O ' ' A' ' 64' ' ' ARG . 6.7 p -136.9 153.31 29.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' HB2' ' HH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -107.58 122.49 46.78 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 174.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.037 HG21 HG21 ' A' ' 47' ' ' ILE . 17.7 t -128.93 138.24 55.09 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -174.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 62' ' ' THR . 2.7 m -123.37 117.4 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 173.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.3 mt-10 -147.4 177.24 9.39 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.666 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.768 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . 9.7 m 89.9 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.325 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 51.2 Cg_exo -54.37 82.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.769 2.312 . . . . 0.0 112.812 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' CB ' ' HB2' ' A' ' 30' ' ' GLU . 6.7 t30 177.77 157.39 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.712 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -56.16 -23.15 33.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -177.43 55.03 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 1.0 OUTLIER -66.27 -68.73 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.461 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 51' ' ' LYS . 3.3 t -116.94 87.7 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.866 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.3 115.61 1.67 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -159.65 -179.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-O 121.963 0.887 . . . . 0.0 111.229 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.664 ' N ' HG23 ' A' ' 33' ' ' ILE . 17.9 mttt -75.77 121.59 22.79 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 103.046 -2.946 . . . . 0.0 103.046 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.45 177.63 22.15 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.145 -1.026 . . . . 0.0 115.133 -175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -106.95 149.48 27.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.319 -0.941 . . . . 0.0 110.943 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.731 HG12 HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -118.57 144.81 25.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 122.672 1.225 . . . . 0.0 113.424 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.0 t -130.32 138.14 54.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.796 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 71.16 73.84 0.18 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.991 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.457 ' HG3' HD21 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -86.11 -44.53 12.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.61 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.87 -1.38 7.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.4 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -64.61 -68.79 0.33 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.774 0.321 . . . . 0.0 110.746 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -149.6 -91.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.581 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.4 t -92.52 175.03 6.98 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.468 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.6 mt -118.37 124.06 46.81 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -121.22 124.24 44.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -130.88 143.62 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.62 -179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.463 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 4.4 ttm -123.94 126.49 46.44 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.269 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.588 ' HB ' ' CA ' ' A' ' 33' ' ' ILE . 6.0 p -103.4 -88.75 0.4 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.181 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.647 ' HB2' HG13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -141.16 -53.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.348 -0.22 . . . . 0.0 110.934 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.673 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.4 tptm -61.55 -14.79 32.67 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.249 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' HG13 ' A' ' 31' ' ' VAL . . . 154.47 -166.85 32.36 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.762 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.0 pt? -124.31 134.57 53.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.29 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 147.24 49.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.153 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 46' ' ' LYS . 22.8 m -119.24 125.88 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.958 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 m -144.1 175.67 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.721 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.25 175.97 5.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.976 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -36.59 -33.44 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -110.69 109.4 19.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 110.999 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 157.93 125.96 0.86 Allowed Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.227 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.431 ' N ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 54.41 -175.16 0.04 OUTLIER 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 23' ' ' VAL . 91.9 m -124.18 122.8 38.77 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.542 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.602 ' HB3' HG13 ' A' ' 22' ' ' VAL . 2.7 p90 -134.77 149.44 50.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.348 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 1.024 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 ptp180 -124.52 123.77 40.84 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.34 141.56 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.56 ' HH2' ' HB2' ' A' ' 21' ' ' GLU . 2.9 m-90 -124.64 124.78 42.94 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.225 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' CE1' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.13 175.68 5.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.995 179.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.14 5.19 7.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.609 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.84 -52.29 0.43 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.87 -178.3 7.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.874 0.368 . . . . 0.0 110.986 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.5 pp -125.73 131.38 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.261 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.434 ' CE ' HD11 ' A' ' 74' ' ' ILE . 7.7 ttp -134.43 154.66 51.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.997 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.415 ' O ' HD13 ' A' ' 74' ' ' ILE . 44.4 mtt85 -123.2 130.39 52.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.704 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.435 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 29.2 mm -124.01 124.64 69.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.063 0.458 . . . . 0.0 111.558 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -127.47 134.57 49.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.696 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.72 139.41 16.41 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 110.915 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.302 0 N-CA-C 112.626 -0.189 . . . . 0.0 112.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.4 mp -76.82 71.07 3.35 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 120.795 0.331 . . . . 0.0 110.929 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.68 127.49 53.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.827 HG23 HG23 ' A' ' 22' ' ' VAL . 2.9 m -143.59 175.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 3.2 tt0 -119.6 122.83 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.916 HG21 ' CG2' ' A' ' 47' ' ' ILE . 47.9 t -131.01 145.29 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.496 HG13 ' OE1' ' A' ' 30' ' ' GLU . 41.7 t -124.66 119.51 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.538 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.503 ' CB ' ' HG3' ' A' ' 61' ' ' ARG . 6.0 pt-20 -146.63 176.3 9.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.754 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 69.28 99.59 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.402 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.12 -17.5 38.9 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.333 2.022 . . . . 0.0 111.652 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -36.78 151.56 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.142 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -53.42 -53.02 57.24 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.8 p -94.6 53.45 1.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.496 ' OE1' HG13 ' A' ' 23' ' ' VAL . 1.5 pp20? -42.73 171.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.399 -178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.729 HG12 ' OG1' ' A' ' 49' ' ' THR . 18.2 t -110.3 99.64 9.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.526 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.6 115.21 1.56 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.669 HG13 ' HB2' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -160.79 -178.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 O-C-N 121.78 -0.835 . . . . 0.0 111.113 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' N ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmtp -74.41 121.66 21.76 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.58 177.68 22.97 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.971 -1.109 . . . . 0.0 114.853 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -110.26 149.41 30.2 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 114.431 -0.885 . . . . 0.0 111.006 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.927 HG12 HG23 ' A' ' 47' ' ' ILE . 32.6 m -120.88 124.23 71.87 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 CA-C-O 121.698 0.761 . . . . 0.0 112.428 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 22.0 t -134.11 149.42 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.538 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.86 95.97 10.4 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.804 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.639 ' HG3' HG22 ' A' ' 41' ' ' THR . 15.1 pt-20 -42.79 -37.25 1.72 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.639 HG22 ' HG3' ' A' ' 40' ' ' GLU . 6.2 t -149.86 40.95 0.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.545 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 46.28 56.88 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.912 0.387 . . . . 0.0 110.95 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.56 -66.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.406 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 p -85.03 158.06 20.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mt -110.07 124.36 51.34 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.622 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.797 ' HB3' HG12 ' A' ' 55' ' ' VAL . 3.5 pttp -115.24 124.38 51.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 37' ' ' VAL . 2.8 mt -127.75 136.57 60.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.904 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.443 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -123.31 128.18 49.58 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.665 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.729 ' OG1' HG12 ' A' ' 31' ' ' VAL . 4.2 p -107.09 -88.22 0.47 Allowed 'General case' 0 C--N 1.352 0.682 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.249 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HB2' HG13 ' A' ' 33' ' ' ILE . 1.1 mt-10 -138.63 -55.61 0.62 Allowed 'General case' 0 N--CA 1.463 0.202 0 O-C-N 122.35 -0.219 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.711 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.66 -16.77 11.67 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.358 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 153.32 -163.14 30.54 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.304 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.1 pt? -127.23 136.59 52.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.916 0.388 . . . . 0.0 110.389 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -126.88 147.44 50.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.797 HG12 ' HB3' ' A' ' 46' ' ' LYS . 28.1 m -120.31 128.04 75.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.098 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.97 148.46 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.514 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.47 132.29 51.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.5 mttt 64.23 65.44 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.341 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 65.01 177.43 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.206 0.527 . . . . 0.0 111.97 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 152.1 -111.1 0.48 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.714 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CB ' ' A' ' 24' ' ' GLU . 5.9 mmp_? -58.68 -163.34 0.0 OUTLIER 'General case' 0 C--O 1.238 0.477 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.493 HG23 ' CB ' ' A' ' 75' ' ' LYS . 4.7 m -123.65 122.76 38.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.617 ' HD1' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -136.6 156.1 49.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.339 0.59 . . . . 0.0 111.934 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.734 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 16.5 mtt180 -124.89 125.04 43.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 20' ' ' VAL . 19.9 m -117.8 138.53 48.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.6 m-90 -124.27 124.78 43.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.601 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -127.26 164.0 22.7 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.683 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -69.44 66.42 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.748 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.69 -35.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.425 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.26 168.21 5.68 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 111.481 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.9 127.88 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.105 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.59 159.43 41.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.822 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.83 128.73 49.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.693 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.617 HG23 ' HD1' ' A' ' 63' ' ' PHE . 1.5 tp -124.48 124.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.006 0.432 . . . . 0.0 111.303 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' CB ' HG23 ' A' ' 62' ' ' THR . 11.0 pttt -126.93 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -107.53 137.83 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.267 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.732 0.301 . . . . 0.0 111.073 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.792 -0.123 . . . . 0.0 112.792 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' HB2' HG23 ' A' ' 37' ' ' VAL . 4.9 mp -144.32 115.84 8.11 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 120.731 0.3 . . . . 0.0 110.797 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.9 mtt -103.99 123.07 46.53 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 64' ' ' ARG . 98.4 t -134.94 146.79 29.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' CB ' ' CH2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -96.24 122.2 38.85 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 103.188 -2.893 . . . . 0.0 103.188 174.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.97 ' CG2' HG21 ' A' ' 47' ' ' ILE . 12.1 t -128.85 137.24 57.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' THR . 3.6 m -123.16 117.01 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.485 ' HB3' ' CD ' ' A' ' 61' ' ' ARG . 16.1 pt-20 -148.5 177.25 9.63 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.257 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 66.85 103.63 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.876 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.91 -5.6 14.93 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.589 2.193 . . . . 0.0 111.759 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -37.45 156.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.007 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -52.38 -49.22 64.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.783 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -79.57 -32.08 41.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.505 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 62.04 150.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.023 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.902 HG22 ' HB2' ' A' ' 51' ' ' LYS . 2.9 t -114.7 91.38 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.039 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.31 115.09 1.57 Allowed Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.637 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -159.18 -179.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 CA-C-O 121.894 0.854 . . . . 0.0 110.698 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.8 mttp -76.39 121.35 22.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -143.84 177.61 22.45 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.416 -1.373 . . . . 0.0 115.427 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.62 148.52 29.22 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.293 -0.953 . . . . 0.0 111.094 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 20' ' ' VAL . 33.9 m -122.44 124.25 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.683 0.754 . . . . 0.0 112.836 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 m -130.71 140.3 49.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.073 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -86.14 115.19 23.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.243 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -43.17 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.274 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.4 p -123.2 41.82 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.448 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.43 63.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.292 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t30 179.46 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.14 156.87 21.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.62 124.19 51.75 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.041 -0.663 . . . . 0.0 111.571 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.772 ' HE2' HD23 ' A' ' 53' ' ' LEU . 1.0 OUTLIER -113.41 124.33 52.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.97 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.4 mp -128.9 140.77 48.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.54 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.505 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 3.9 ppp? -119.68 124.36 46.07 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 120.65 -0.42 . . . . 0.0 109.888 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.584 HG21 ' HB ' ' A' ' 22' ' ' VAL . 23.0 p -131.23 -92.72 0.41 Allowed 'General case' 0 C--N 1.354 0.781 0 O-C-N 123.568 0.543 . . . . 0.0 112.013 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.635 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 49.4 tt0 -90.39 -91.28 0.14 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.902 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -41.48 -29.68 0.17 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 146.46 -135.61 5.87 Favored Glycine 0 C--O 1.241 0.557 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.257 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.772 HD23 ' HE2' ' A' ' 46' ' ' LYS . 6.4 mp -100.37 124.96 46.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.192 0.52 . . . . 0.0 111.998 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -128.49 138.11 52.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.947 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' CG ' ' A' ' 46' ' ' LYS . 29.8 m -111.95 127.07 69.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 111.812 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -143.96 175.37 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.284 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -98.48 175.37 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.734 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -28.48 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -111.87 164.99 12.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.036 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.1 -84.16 0.36 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.606 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.485 ' CD ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -82.35 -177.68 6.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.893 0.378 . . . . 0.0 110.866 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 23' ' ' VAL . 40.0 m -124.03 123.17 39.78 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.657 ' HB3' HG13 ' A' ' 22' ' ' VAL . 3.4 p90 -139.14 162.39 35.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.458 0.646 . . . . 0.0 111.965 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 1.035 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -124.59 123.67 40.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.831 HG23 ' CG2' ' A' ' 20' ' ' VAL . 11.8 p -108.84 139.26 32.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.484 ' CH2' ' CB ' ' A' ' 21' ' ' GLU . 1.9 m-90 -124.03 124.21 42.04 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.919 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' CD2' ' HG ' ' A' ' 18' ' ' LEU . 4.2 t80 -120.23 159.19 25.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.952 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.33 66.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.004 0.43 . . . . 0.0 110.667 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 67' ' ' TYR . . . 170.79 -50.39 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.699 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.32 166.97 27.38 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.938 0.399 . . . . 0.0 111.269 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 41.2 pt -128.04 137.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.454 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 56.4 tpp -136.76 160.1 39.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.76 128.93 55.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.594 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.498 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.5 mp -124.09 124.29 68.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.042 0.449 . . . . 0.0 111.577 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 124.95 43.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.8 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.57 134.76 11.33 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.428 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t70 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.795 0.331 . . . . 0.0 111.011 179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' CD ' ' A' ' 68' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.939 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.5 mp -128.94 93.34 3.58 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-O 120.702 0.286 . . . . 0.0 110.619 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.453 ' O ' ' HE3' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -104.49 123.63 47.84 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.99 HG11 HG13 ' A' ' 37' ' ' VAL . 8.1 p -134.32 146.8 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.6 mt-10 -100.18 121.51 41.56 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.774 HG21 HG12 ' A' ' 47' ' ' ILE . 43.9 t -133.41 146.84 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 52.9 t -124.55 118.59 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.197 173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 4.1 mt-10 -147.1 177.06 9.46 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.482 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.709 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 75.84 107.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.587 179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.96 -12.63 35.48 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.389 2.059 . . . . 0.0 111.579 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -40.0 159.89 0.01 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.807 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.9 m170 -59.23 -49.47 77.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.362 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.3 t -88.99 -27.42 20.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.493 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 45.6 -171.77 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.782 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.897 HG22 ' OG1' ' A' ' 49' ' ' THR . 13.0 p -136.3 109.72 9.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.937 0 CA-C-O 121.307 0.575 . . . . 0.0 110.719 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.634 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -133.33 115.71 1.59 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG23 ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -160.3 -179.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.521 -0.988 . . . . 0.0 111.415 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.651 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -76.69 121.28 23.05 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 102.555 -3.128 . . . . 0.0 102.555 176.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.37 177.76 22.75 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 119.924 -1.131 . . . . 0.0 114.662 -175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -109.42 146.5 34.37 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.617 -0.791 . . . . 0.0 111.441 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.99 HG13 HG11 ' A' ' 20' ' ' VAL . 1.6 m -124.19 125.87 71.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-O 121.379 0.609 . . . . 0.0 111.805 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.21 135.6 62.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.647 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.432 ' OD1' ' HG ' ' A' ' 45' ' ' LEU . 5.9 m-20 -85.22 113.38 21.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.443 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 44' ' ' THR . 0.6 OUTLIER -46.04 -46.14 16.46 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.378 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.4 m -162.16 50.03 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.746 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 58.12 58.36 3.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.64 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -175.76 -74.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.658 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 40' ' ' GLU . 2.1 t -78.05 139.96 39.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HG ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -115.01 124.77 52.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.818 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -106.37 124.39 49.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.774 HG12 HG21 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -122.61 130.49 74.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.392 -178.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.648 ' N ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -123.22 124.74 43.69 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.897 ' OG1' HG22 ' A' ' 31' ' ' VAL . 1.6 p -109.27 -89.22 0.48 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 119.909 -0.717 . . . . 0.0 111.325 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.571 ' HB2' HG21 ' A' ' 33' ' ' ILE . 37.0 tt0 -130.43 -59.86 1.01 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 122.172 -0.33 . . . . 0.0 111.606 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.807 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.27 -8.01 1.49 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.401 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 144.76 -166.4 27.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.538 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.2 pt? -127.89 138.13 52.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.992 0.425 . . . . 0.0 111.109 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.15 149.1 52.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.377 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG12 ' HB3' ' A' ' 46' ' ' LYS . 30.3 m -112.21 127.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 111.139 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.425 HG21 ' OE2' ' A' ' 24' ' ' GLU . 2.9 m -143.73 175.5 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.56 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.81 175.78 6.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.29 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.36 -31.45 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 111.617 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 154.34 19.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.29 129.34 4.57 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.439 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 5.8 mmp_? 56.17 -172.02 0.07 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.457 0.17 . . . . 0.0 110.637 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.4 m -124.26 122.87 38.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.119 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.5 p90 -135.51 151.74 50.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.841 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.9 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.2 mmt180 -124.37 123.84 41.05 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG11 ' OH ' ' A' ' 67' ' ' TYR . 10.8 p -118.82 146.41 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 1.6 m-90 -124.54 124.62 42.67 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 113.454 -1.703 . . . . 0.0 110.321 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' OH ' HG11 ' A' ' 65' ' ' VAL . 3.6 m-85 -110.89 175.39 5.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.123 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.423 ' CD ' ' HA2' ' A' ' 17' ' ' GLY . 1.9 mtmp? -73.92 61.57 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.631 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.72 -67.67 0.18 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.0 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -124.05 168.73 12.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.048 0.452 . . . . 0.0 111.528 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.5 pt -128.57 139.36 52.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.325 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.03 160.76 37.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.51 130.2 52.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.705 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 63' ' ' PHE . 3.0 mp -123.95 124.76 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.053 0.454 . . . . 0.0 111.599 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -125.35 128.58 48.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.654 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.3 152.82 21.44 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.725 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.249 -0.34 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 0.8 OUTLIER -120.72 159.95 24.32 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 120.785 0.326 . . . . 0.0 110.727 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.562 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 16.8 mtp -109.92 124.62 51.7 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.064 HG13 ' O ' ' A' ' 64' ' ' ARG . 81.9 t -130.12 141.3 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.907 -0.495 . . . . 0.0 111.876 -176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' OE2' ' CE3' ' A' ' 66' ' ' TRP . 0.6 OUTLIER -88.51 121.09 30.52 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 175.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.995 ' CG2' HG21 ' A' ' 47' ' ' ILE . 17.7 t -129.37 137.83 55.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -174.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.09 118.07 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-N 114.019 -1.446 . . . . 0.0 107.519 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 5.5 mt-10 -146.61 176.21 10.01 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.252 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.432 ' OG ' HG12 ' A' ' 31' ' ' VAL . 1.4 m 61.87 120.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.339 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.53 11.93 3.2 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.735 2.29 . . . . 0.0 112.418 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.28 168.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.402 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -57.28 -39.62 76.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.172 0.511 . . . . 0.0 110.263 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -103.61 -27.03 12.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.35 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 61.11 171.8 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.101 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.875 HG22 ' OG1' ' A' ' 49' ' ' THR . 2.7 p -122.35 94.97 3.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.682 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 22' ' ' VAL . . . -133.33 114.48 1.38 Allowed Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.733 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -160.43 -175.39 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 O-C-N 121.625 -0.927 . . . . 0.0 110.214 179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 4.0 mmpt? -76.05 120.78 21.84 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 102.286 -3.227 . . . . 0.0 102.286 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.56 176.37 19.94 Favored Glycine 0 CA--C 1.501 -0.811 0 C-N-CA 119.579 -1.295 . . . . 0.0 115.054 -174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 145.3 31.6 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.502 -0.849 . . . . 0.0 111.633 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.77 HG11 HG21 ' A' ' 20' ' ' VAL . 19.0 m -123.22 124.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.04 142.91 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.277 -1.329 . . . . 0.0 109.594 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.92 118.37 27.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.27 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.93 -44.36 9.7 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.337 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -163.7 45.35 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 59.94 57.36 3.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -172.1 -65.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.931 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.8 p -84.83 158.04 20.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.9 124.37 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.332 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.634 ' CG ' HG12 ' A' ' 55' ' ' VAL . 6.9 ttpt -116.7 124.31 49.37 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.995 HG21 ' CG2' ' A' ' 22' ' ' VAL . 2.9 mp -130.34 143.87 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.519 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.473 ' HG3' HD12 ' A' ' 53' ' ' LEU . 0.4 OUTLIER -124.72 129.8 51.19 Favored 'General case' 0 C--O 1.251 1.179 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.044 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.875 ' OG1' HG22 ' A' ' 31' ' ' VAL . 4.4 p -134.77 -114.62 0.2 Allowed 'General case' 0 C--N 1.362 1.132 0 O-C-N 123.803 0.689 . . . . 0.0 111.611 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.788 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.19 -89.9 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' CB ' ' HB ' ' A' ' 31' ' ' VAL . 1.3 tttm -44.15 -57.99 3.11 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.2 -135.68 2.62 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.724 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD23 ' CG ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -103.07 127.43 50.33 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.046 -0.577 . . . . 0.0 112.238 -178.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -128.33 137.95 52.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.763 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.634 HG12 ' CG ' ' A' ' 46' ' ' LYS . 27.2 m -118.23 127.26 75.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 112.115 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 57' ' ' ALA . 2.5 t -139.96 166.3 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.659 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' ARG . . . -123.51 123.75 41.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.372 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER 25.24 39.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 178.46 -168.26 0.08 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.059 0.457 . . . . 0.0 111.399 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.37 129.09 0.01 OUTLIER Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.986 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' N ' ' NE ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 58.99 -175.36 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.516 0.198 . . . . 0.0 110.931 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -123.96 123.06 39.56 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.572 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.612 ' HB3' HG13 ' A' ' 22' ' ' VAL . 1.7 p90 -133.71 147.15 51.34 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.944 0.402 . . . . 0.0 111.164 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 1.064 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -123.78 122.59 38.45 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.722 ' HA ' HG22 ' A' ' 20' ' ' VAL . 12.3 p -98.01 126.38 51.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.618 ' HB2' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -126.17 125.17 42.03 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 122.077 0.941 . . . . 0.0 111.155 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HB3' HD22 ' A' ' 18' ' ' LEU . 2.1 p90 -132.35 169.71 16.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.886 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -71.66 61.57 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.411 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.38 -44.27 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.665 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 163.41 27.64 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.439 0.638 . . . . 0.0 112.225 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.618 HG22 ' HB2' ' A' ' 66' ' ' TRP . 9.2 pt -126.48 127.66 70.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.179 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.8 mmt -130.86 144.52 51.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.18 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -105.21 126.03 51.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.429 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 25.5 mt -124.36 124.7 69.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.939 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -131.6 147.05 52.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.04 170.98 35.11 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.29 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.912 0.386 . . . . 0.0 111.071 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.245 0 N-CA-C 112.881 -0.087 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.847 HD23 ' CE2' ' A' ' 67' ' ' TYR . 0.0 OUTLIER -94.84 90.97 6.22 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-O 120.801 0.334 . . . . 0.0 110.593 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.9 ttt -103.41 124.91 49.6 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.772 HG23 HG23 ' A' ' 22' ' ' VAL . 2.8 m -143.77 175.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.4 mt-10 -116.81 122.07 43.37 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 174.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.994 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.5 t -127.03 131.77 70.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -175.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.22 117.17 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 122.295 1.045 . . . . 0.0 109.004 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.744 ' HG2' HG11 ' A' ' 56' ' ' VAL . 1.3 mp0 -148.35 176.16 10.5 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.264 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.626 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 1.2 m 88.55 -16.78 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 25' ' ' SER . 20.0 Cg_endo -61.27 -19.51 64.18 Favored 'Trans proline' 0 C--N 1.361 1.186 0 CA-C-N 121.778 1.671 . . . . 0.0 109.722 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -16.34 61.25 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.385 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.7 -67.11 0.09 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.432 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -96.63 -136.74 0.25 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.447 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 4.3 tt0 -162.58 104.33 1.07 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.789 0.328 . . . . 0.0 111.109 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.888 HG12 ' OG1' ' A' ' 49' ' ' THR . 2.5 t -151.45 94.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.038 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.093 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.869 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -132.82 114.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -162.55 -172.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 122.682 1.229 . . . . 0.0 110.415 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -79.75 122.4 26.54 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 177.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.99 177.46 23.43 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.606 -1.283 . . . . 0.0 115.443 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.02 147.89 32.69 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.003 -1.099 . . . . 0.0 110.173 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.66 ' O ' HD13 ' A' ' 18' ' ' LEU . 33.9 m -123.53 125.31 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' O ' HD13 ' A' ' 45' ' ' LEU . 21.5 t -127.44 130.09 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.877 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -83.78 112.32 19.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.518 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -47.1 -54.18 11.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.2 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 41' ' ' THR . 15.1 m -150.07 44.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.735 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.35 64.05 1.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.624 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -179.05 -82.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -77.08 138.16 39.38 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -112.18 123.96 51.4 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.344 -178.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.781 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -93.9 123.63 37.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.994 ' CG2' HG21 ' A' ' 22' ' ' VAL . 7.6 mt -128.83 139.69 51.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 120.544 -0.462 . . . . 0.0 112.211 -178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.532 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 35.2 ttm -123.5 124.41 42.79 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.888 ' OG1' HG12 ' A' ' 31' ' ' VAL . 71.3 p -97.97 -68.1 0.82 Allowed 'General case' 0 C--N 1.347 0.481 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.456 -178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.769 ' N ' HG13 ' A' ' 33' ' ' ILE . 8.3 tt0 -174.83 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -70.55 -9.97 58.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 155.36 -179.77 31.09 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.517 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 53' ' ' LEU . 1.9 pt? -126.3 133.37 51.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.336 -0.432 . . . . 0.0 109.94 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 172.96 11.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.212 0.529 . . . . 0.0 111.653 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.781 HG12 ' HG2' ' A' ' 46' ' ' LYS . 31.1 m -103.78 129.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.483 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.744 HG11 ' HG2' ' A' ' 24' ' ' GLU . 16.6 m -133.93 158.51 42.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.884 0.85 . . . . 0.0 112.396 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 59' ' ' ARG . . . -143.84 176.15 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.348 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -59.12 68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.912 0.387 . . . . 0.0 111.262 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 57' ' ' ALA . 3.4 mtm180 -143.68 -162.99 1.56 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.822 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 61' ' ' ARG . . . -54.7 113.58 3.64 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.888 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 150.86 163.08 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.567 0.747 . . . . 0.0 109.081 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' HG3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -123.95 123.05 39.55 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.974 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.22 140.0 49.79 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.371 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 8.3 mtt180 -124.57 125.79 44.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 20' ' ' VAL . 16.6 m -123.18 139.13 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.709 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.4 m-90 -124.08 124.78 43.28 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.855 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.847 ' CE2' HD23 ' A' ' 18' ' ' LEU . 7.3 m-85 -112.0 175.13 5.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.454 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -81.39 59.48 4.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.882 0.372 . . . . 0.0 110.65 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.66 -50.48 0.14 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.704 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.78 163.81 31.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.46 129.86 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.37 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.67 147.58 52.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.857 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.2 129.32 49.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.6 mt -124.12 124.48 68.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.18 0.514 . . . . 0.0 111.407 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.802 ' HG3' HG23 ' A' ' 62' ' ' THR . 56.4 tttt -125.81 129.45 49.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.883 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.68 124.59 6.09 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.32 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 120.802 0.334 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.651 ' C ' HD12 ' A' ' 18' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.638 -0.185 . . . . 0.0 112.638 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.713 ' HB3' HG23 ' A' ' 37' ' ' VAL . 5.0 mp -113.99 102.75 10.48 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 121.041 0.448 . . . . 0.0 110.637 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.412 ' O ' ' CE3' ' A' ' 66' ' ' TRP . 30.8 mtt -107.29 123.56 48.5 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.022 HG13 ' O ' ' A' ' 64' ' ' ARG . 97.5 t -132.82 145.22 34.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.577 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 2.6 tt0 -87.26 122.2 30.73 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 173.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.957 HG21 ' CG2' ' A' ' 47' ' ' ILE . 22.2 t -126.49 133.73 68.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -174.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.64 116.83 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.97 176.96 9.75 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.389 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 61.7 114.48 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.639 179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.15 10.55 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.541 2.161 . . . . 0.0 111.992 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -43.23 161.67 0.02 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.544 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -30.68 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.673 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.1 t -103.31 -28.54 11.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 62.0 152.38 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.773 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.864 HG13 ' N ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -115.79 95.69 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.589 ' O ' HG12 ' A' ' 33' ' ' ILE . . . -132.66 115.19 1.55 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.641 ' HB ' ' N ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -159.57 -179.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-O 121.592 0.71 . . . . 0.0 110.464 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 4.4 mtpm? -75.98 121.65 23.04 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 48' ' ' MET . . . -144.11 177.22 22.91 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 118.791 -1.671 . . . . 0.0 116.164 -174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.96 145.67 28.37 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 113.87 -1.165 . . . . 0.0 110.72 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.713 HG23 ' HB3' ' A' ' 18' ' ' LEU . 3.1 m -123.64 127.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.0 t -127.48 132.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.312 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.93 107.87 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 0.0 110.801 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.7 91.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m 58.6 31.83 21.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 57.95 65.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.783 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -165.5 -76.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.635 HG23 ' HB2' ' A' ' 57' ' ' ALA . 22.9 m -81.87 150.27 27.87 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -112.04 123.81 51.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.537 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.583 ' HG2' HG12 ' A' ' 55' ' ' VAL . 7.2 mtpp -113.45 123.1 49.25 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.957 ' CG2' HG21 ' A' ' 22' ' ' VAL . 5.2 mt -132.05 144.33 37.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.102 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.511 ' O ' ' HA3' ' A' ' 35' ' ' GLY . 5.7 ttp -124.02 124.21 42.06 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.1 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.562 ' HB ' ' N ' ' A' ' 33' ' ' ILE . 9.5 p -132.21 -92.94 0.37 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.641 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 3.9 tp10 -89.4 -93.89 0.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.864 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -38.53 -30.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 151.83 -142.73 9.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.393 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.14 128.25 55.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 111.008 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 148.25 52.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.631 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.583 HG12 ' HG2' ' A' ' 46' ' ' LYS . 35.9 m -115.57 126.12 73.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.347 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' HD3' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -129.39 140.05 50.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.578 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -124.75 124.91 43.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.665 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 58.46 111.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.48 174.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.14 0.495 . . . . 0.0 111.706 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 47.22 11.81 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.012 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HD3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER 170.12 126.27 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 80.1 m -124.32 123.69 40.76 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.937 0.399 . . . . 0.0 110.286 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.4 OUTLIER -144.02 174.22 11.05 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.516 0.674 . . . . 0.0 111.84 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 1.022 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -124.44 124.51 42.47 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 67' ' ' TYR . 9.1 p -104.31 141.5 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.577 ' CH2' ' HB2' ' A' ' 21' ' ' GLU . 2.0 m-90 -124.45 124.25 41.9 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 113.313 -1.767 . . . . 0.0 109.75 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 65' ' ' VAL . 69.5 m-85 -115.28 175.47 5.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.935 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 56.21 2.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.857 0.361 . . . . 0.0 110.447 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.0 -52.81 0.1 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.97 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 165.61 26.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.934 0.397 . . . . 0.0 111.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.29 134.66 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.307 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.9 mmt -140.75 168.47 19.73 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.995 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 mtt-85 -101.99 130.12 48.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.46 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 HG21 ' CE2' ' A' ' 63' ' ' PHE . 1.4 tt -124.72 124.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.793 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.45 140.12 51.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.545 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.31 124.89 9.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 t0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.879 0.371 . . . . 0.0 111.173 -179.783 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.379 -0.288 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.668 ' HB3' HG23 ' A' ' 37' ' ' VAL . 1.9 mp -95.12 78.24 3.52 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 120.807 0.336 . . . . 0.0 110.866 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.39 127.07 49.56 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.752 HG21 HG13 ' A' ' 37' ' ' VAL . 12.1 m -142.88 175.15 4.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -121.63 121.31 37.1 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 63' ' ' PHE . 33.1 t -131.72 143.41 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 116.188 1.922 . . . . 0.0 116.188 -175.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.72 117.98 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.29 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.72 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -148.25 174.63 11.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.992 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.681 ' N ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER 34.5 41.13 0.17 Allowed Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.322 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.72 ' HD3' ' C ' ' A' ' 24' ' ' GLU . 75.8 Cg_endo -99.81 6.33 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 122.797 2.331 . . . . 0.0 109.519 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.44 -28.31 9.44 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.438 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 -44.07 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.17 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 30' ' ' GLU . 1.7 p -125.18 -102.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.226 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 25' ' ' SER . 0.9 OUTLIER 166.86 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 O-C-N 122.401 -0.187 . . . . 0.0 111.444 179.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.977 HG22 ' HB2' ' A' ' 51' ' ' LYS . 1.5 t -130.74 82.11 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.011 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.605 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -133.13 114.1 1.34 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 176.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.82 HG12 ' C ' ' A' ' 49' ' ' THR . 0.4 OUTLIER -160.89 -175.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 O-C-N 121.635 -0.921 . . . . 0.0 110.227 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -73.87 121.06 20.32 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 102.225 -3.25 . . . . 0.0 102.225 175.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.85 177.57 20.77 Favored Glycine 0 C--N 1.313 -0.739 0 C-N-CA 119.601 -1.285 . . . . 0.0 115.403 -174.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.495 ' O ' HD12 ' A' ' 47' ' ' ILE . 9.6 tt0 -111.4 144.39 40.69 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 113.935 -1.132 . . . . 0.0 111.016 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.834 ' CG1' HD13 ' A' ' 47' ' ' ILE . 27.8 m -123.99 125.89 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.505 0.669 . . . . 0.0 112.535 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.4 m -128.28 136.7 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.366 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.04 107.4 17.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.612 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.15 95.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m 54.47 32.77 17.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.05 69.97 0.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.892 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.29 -80.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 57' ' ' ALA . 1.4 m -85.97 160.18 19.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.6 mt -107.95 124.13 49.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.07 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.709 ' HE2' HD23 ' A' ' 53' ' ' LEU . 6.8 tttt -110.26 124.23 51.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.834 HD13 ' CG1' ' A' ' 37' ' ' VAL . 3.0 tp -127.14 135.94 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.24 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.609 ' H ' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -122.35 124.32 43.43 Favored 'General case' 0 C--O 1.251 1.141 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.885 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.82 ' C ' HG12 ' A' ' 33' ' ' ILE . 81.4 p -135.18 -104.02 0.22 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.129 0.893 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -79.71 -85.6 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.977 ' HB2' HG22 ' A' ' 31' ' ' VAL . 1.7 tttp -43.55 -28.5 0.38 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.58 -131.68 5.45 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.869 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.709 HD23 ' HE2' ' A' ' 46' ' ' LYS . 0.7 OUTLIER -99.13 125.45 44.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.124 0.487 . . . . 0.0 111.625 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 137.43 52.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.177 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 46' ' ' LYS . 15.4 m -109.0 128.15 65.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.669 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.9 t -128.37 137.97 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.111 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -126.25 131.92 51.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.676 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 62.2 75.7 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.42 -179.02 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.318 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' CZ ' ' A' ' 63' ' ' PHE . . . 126.64 122.58 2.57 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.138 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 13.9 mmt180 68.33 -172.98 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.708 0.254 . . . . 0.0 110.456 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.7 m -124.26 124.15 41.79 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.298 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.774 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -134.77 153.7 51.91 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.247 0.546 . . . . 0.0 111.684 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.691 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 1.7 mtm-85 -123.96 124.91 43.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.748 ' HA ' HG12 ' A' ' 20' ' ' VAL . 58.0 t -115.31 138.43 45.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.65 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.5 m-90 -124.11 124.6 42.87 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.858 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.47 ' CE1' HG11 ' A' ' 65' ' ' VAL . 83.4 m-85 -110.35 175.3 5.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.182 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.35 58.48 2.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.415 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.0 -56.21 0.14 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.985 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -132.75 164.58 26.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.962 0.411 . . . . 0.0 111.519 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.35 129.66 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.267 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.4 mtp -136.02 158.08 45.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.024 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 133.48 55.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.621 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.756 HG23 ' HD1' ' A' ' 63' ' ' PHE . 7.0 tp -127.0 133.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.235 0.541 . . . . 0.0 111.549 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.22 145.93 52.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.693 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.36 145.96 27.12 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.603 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.979 -0.048 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.632 ' HB3' HG23 ' A' ' 37' ' ' VAL . 4.4 mp -92.88 101.64 14.0 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 120.745 0.307 . . . . 0.0 110.341 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.05 126.34 51.1 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.868 ' CG1' HG13 ' A' ' 65' ' ' VAL . 5.9 m -144.0 175.36 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' HB2' ' CH2' ' A' ' 66' ' ' TRP . 1.7 mm-40 -118.72 121.34 39.88 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 47' ' ' ILE . 14.3 t -130.66 140.9 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -175.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.5 118.32 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.191 -1.368 . . . . 0.0 107.864 174.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' HG3' HG13 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -146.7 176.3 9.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.162 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.645 ' OG ' HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 64.36 104.53 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.378 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.26 -5.19 13.21 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.554 2.169 . . . . 0.0 112.106 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -38.76 157.99 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.907 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -50.89 -51.84 47.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.025 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m -79.53 -34.33 41.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.726 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 31' ' ' VAL . 3.2 tt0 62.58 149.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.011 HG22 ' OG1' ' A' ' 49' ' ' THR . 8.7 p -111.05 93.26 2.4 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 122.17 0.986 . . . . 0.0 109.186 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' CG2' ' A' ' 33' ' ' ILE . . . -135.25 114.61 1.26 Allowed Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.681 HG12 ' N ' ' A' ' 50' ' ' GLU . 0.8 OUTLIER -163.22 -173.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.622 -0.928 . . . . 0.0 109.841 178.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -73.26 122.22 21.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 176.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -144.04 177.35 22.78 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.277 -0.963 . . . . 0.0 114.748 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -110.65 148.9 31.28 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 114.397 -0.902 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.676 HG21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -128.32 138.68 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.591 0.71 . . . . 0.0 112.666 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.53 131.48 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.1 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.805 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 24.4 m-20 72.16 74.73 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.815 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' HG2' HD21 ' A' ' 45' ' ' LEU . 2.8 tm-20 -88.53 -64.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.416 HG23 ' OE1' ' A' ' 40' ' ' GLU . 14.5 p -103.21 24.75 10.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -99.8 -78.25 0.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.637 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -137.08 -106.03 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.253 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.1 p -82.64 151.8 26.15 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -107.96 124.13 49.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.288 -179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.888 ' CG ' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -108.87 123.65 49.4 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.591 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.922 HD11 HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -125.95 129.39 72.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.504 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.79 ' HB3' HD13 ' A' ' 53' ' ' LEU . 28.2 ptm -123.8 124.54 42.91 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.388 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 1.011 ' OG1' HG22 ' A' ' 31' ' ' VAL . 3.1 p -112.25 -90.87 0.49 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.681 ' N ' HG12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -129.57 -58.34 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.449 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.796 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.4 tptp -55.02 -16.3 2.71 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.636 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.53 -162.28 29.02 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.077 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 48' ' ' MET . 14.2 tp -121.84 124.81 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.989 -0.605 . . . . 0.0 110.348 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 154.24 38.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.824 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.888 HG12 ' CG ' ' A' ' 46' ' ' LYS . 34.9 m -114.26 127.72 71.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.341 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -143.71 175.57 3.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.322 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.544 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -113.83 175.23 5.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.206 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -68.79 67.7 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.124 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.5 72.68 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.944 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' CZ ' ' A' ' 63' ' ' PHE . . . 160.24 144.92 4.12 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.329 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER 58.37 -177.39 0.08 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.3 m -124.83 124.16 41.5 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.862 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -131.84 147.26 52.47 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.0 0.429 . . . . 0.0 111.296 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.717 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -124.38 124.74 43.0 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG13 ' CG1' ' A' ' 20' ' ' VAL . 25.3 t -119.39 139.93 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.663 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 3.6 m-90 -123.54 124.79 43.61 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.152 -1.385 . . . . 0.0 109.748 177.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -123.43 175.57 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.998 179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.73 7.11 9.17 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.14 -32.85 1.44 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.734 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.8 -175.35 0.28 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.627 0.251 . . . . 0.0 110.768 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -124.17 135.58 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.315 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mmt -135.43 156.86 48.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.908 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -126.85 134.31 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.017 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 74' ' ' ILE . 5.9 tp -124.01 124.66 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 129.72 49.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.986 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -119.36 160.25 14.38 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.341 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 111.03 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.737 HD13 ' CD1' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -97.15 113.09 24.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-O 120.802 0.334 . . . . 0.0 110.361 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.3 ttt -104.68 127.43 52.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.854 HG23 HG23 ' A' ' 22' ' ' VAL . 2.3 m -143.75 175.63 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HB3' ' CH2' ' A' ' 66' ' ' TRP . 4.3 tt0 -120.08 122.23 40.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.997 HG21 ' CG2' ' A' ' 47' ' ' ILE . 39.7 t -130.4 142.15 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.599 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -175.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.55 118.84 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.873 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 61' ' ' ARG . 6.3 pt-20 -146.22 176.0 10.08 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.274 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.76 ' OG ' HG23 ' A' ' 31' ' ' VAL . 99.6 p 54.57 102.58 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.659 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.22 -2.9 11.27 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.39 2.06 . . . . 0.0 111.72 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -35.16 155.14 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.386 0.674 . . . . 0.0 112.113 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -47.58 -35.18 8.76 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.173 0.511 . . . . 0.0 110.032 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 1.8 p -113.43 66.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.458 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -37.56 147.25 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.84 HG12 ' OG1' ' A' ' 49' ' ' THR . 6.3 t -105.96 85.62 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.081 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 33' ' ' ILE . . . -134.26 114.94 1.38 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.72 HG12 ' C ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -161.57 -174.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 CA-C-O 121.848 0.832 . . . . 0.0 109.915 178.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 82.3 mttt -71.36 122.01 19.57 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.59 177.65 22.24 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.622 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -110.01 149.52 29.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.114 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.849 HG12 HG23 ' A' ' 47' ' ' ILE . 29.8 m -122.31 124.96 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.37 0.605 . . . . 0.0 112.515 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.75 HG23 ' HG3' ' A' ' 46' ' ' LYS . 13.7 m -129.19 137.93 55.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.385 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.86 118.18 26.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.671 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 41' ' ' THR . 4.6 tt0 -57.77 99.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.997 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 40' ' ' GLU . 14.0 t 44.63 38.34 2.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.383 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 59.02 68.36 0.82 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -166.64 -79.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.59 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.809 HG23 ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -87.23 163.3 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.929 179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -111.39 124.28 51.94 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.811 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -120.99 124.71 45.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.948 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.997 ' CG2' HG21 ' A' ' 22' ' ' VAL . 1.7 mp -127.85 137.87 56.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.102 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.436 ' HB3' ' CB ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -124.91 129.59 50.69 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.254 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.84 ' OG1' HG12 ' A' ' 31' ' ' VAL . 20.7 p -106.05 -93.64 0.37 Allowed 'General case' 0 C--N 1.352 0.675 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.575 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.712 ' CB ' HG21 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 -58.35 0.91 Allowed 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 122.327 -0.233 . . . . 0.0 111.591 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.838 ' HB3' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.28 -18.08 14.89 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.647 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.535 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 157.69 -163.53 32.68 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.517 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 53' ' ' LEU . 2.3 pt? -128.1 139.16 52.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.954 0.407 . . . . 0.0 110.771 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -124.78 145.2 49.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.694 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.811 HG12 ' HB3' ' A' ' 46' ' ' LYS . 33.9 m -123.04 127.61 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.179 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.57 ' O ' HG22 ' A' ' 44' ' ' THR . 10.6 p -138.55 163.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.216 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.809 ' HB2' HG23 ' A' ' 44' ' ' THR . . . -129.07 141.62 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.767 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 73.57 -68.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.234 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.1 156.66 41.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.92 0.391 . . . . 0.0 111.405 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.552 ' HA3' HG21 ' A' ' 56' ' ' VAL . . . 154.71 124.48 0.92 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.533 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.476 ' HB3' ' HA ' ' A' ' 24' ' ' GLU . 6.1 mmp_? 63.89 -175.8 0.16 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.3 m -124.28 123.58 40.53 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.547 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.796 ' HB3' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -135.7 154.03 51.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.557 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.811 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 mtp180 -125.4 127.52 46.69 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG12 HG11 ' A' ' 20' ' ' VAL . 16.0 m -119.0 140.13 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 20' ' ' VAL . 2.7 m-90 -125.61 128.43 47.88 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.126 177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.737 ' CD1' HD13 ' A' ' 18' ' ' LEU . 35.4 t80 -126.8 163.03 24.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.516 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt -70.03 65.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.906 0.384 . . . . 0.0 110.82 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.76 -43.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.613 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -160.72 170.64 20.37 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.893 0.377 . . . . 0.0 111.137 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -127.62 135.7 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.276 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.1 mtt -136.69 160.12 39.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -123.1 134.43 54.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.671 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.71 HD13 ' CE2' ' A' ' 63' ' ' PHE . 2.1 mt -123.78 124.64 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.651 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.95 126.81 46.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 125.34 6.9 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.615 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.816 0.341 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 stop_ save_